infecti
diseas
claim
million
live
year
robust
accur
diagnost
essenti
tool
identifi
risk
need
treatment
lowresourc
set
inorgan
complex
metalbas
nanomateri
continu
drive
develop
diagnost
platform
strategi
enabl
infecti
diseas
detect
lowresourc
set
review
highlight
work
past
year
inorgan
chemistri
nanotechnolog
implement
core
compon
make
diagnost
test
first
present
inorgan
biomark
properti
leverag
infecti
diseas
detect
follow
section
detail
metalbas
technolog
employ
sampl
prepar
biomark
isol
sampl
matric
describ
inorganicand
nanomaterialbas
probe
util
pointofcar
diagnost
signal
gener
follow
section
discuss
instrument
signal
readout
resourcelimit
set
next
highlight
detect
nucleic
acid
point
care
emerg
applic
inorgan
chemistri
lastli
consid
challeng
remain
translat
aforement
diagnost
platform
lowresourc
set
william
osler
one
founder
modern
american
medicin
state
diagnosi
drug
chief
weapon
offenc
despit
medic
advanc
centuri
infecti
diseas
remain
major
global
health
issu
continu
claim
million
live
year
lowand
middleincom
countri
lmic
global
commun
move
toward
control
elimin
infecti
diseas
becom
evid
press
need
diagnost
strategi
appli
primari
health
care
set
review
shine
spotlight
appli
use
inorgan
chemistri
advanc
concept
metalsinmedicin
beyond
therapeut
vaccin
realm
diagnost
enabl
new
tool
meet
global
challeng
world
health
organ
depict
lmic
health
care
access
infrastructur
tier
pyramid
structur
bestequip
facil
least
access
facil
least
amount
resourc
common
figur
system
level
facil
primari
care
set
littl
laboratori
infrastructur
train
personnel
advanc
diagnost
technolog
lmic
urban
rural
level
facil
frequent
lack
essenti
resourc
consist
electr
clean
run
water
district
hospit
level
region
laboratori
level
nation
refer
laboratori
level
advanc
diagnost
technolog
avail
increas
infrastructur
howev
facil
often
inaccess
patient
need
due
geographi
cost
lack
transport
consid
case
earli
human
immunodefici
viru
hiv
diagnosi
expos
infant
coulibali
et
al
highlight
challeng
face
popul
burkina
faso
studi
hivposit
mother
advis
attend
week
postnat
appoint
nearest
primari
healthcar
facil
collect
dri
blood
spot
sampl
expos
infant
qualifi
sampl
collect
technician
often
avail
month
mother
would
return
clinic
day
test
collect
dri
blood
spot
sampl
sent
districtlevel
hospit
level
sent
sampl
refer
laboratori
level
tertiari
laboratori
determin
viral
load
perform
polymeras
chain
reaction
pcr
detect
hiv
genet
materi
test
result
follow
circuit
path
back
patient
process
could
take
long
four
month
addit
case
posit
dri
blood
spot
result
process
repeat
order
valid
origin
result
contrast
highrisk
newborn
unit
state
screen
hiv
birth
addit
test
week
month
month
patient
result
usual
avail
within
day
sampl
collect
allow
immedi
antiretrovir
treatment
hivposit
children
consequ
diagnost
effici
versu
ineffici
could
strike
burkina
faso
studi
hivposit
infant
die
antiretrovir
therapi
could
even
start
earli
treatment
initi
us
improv
infant
surviv
remark
stark
dispar
respons
time
two
set
show
devast
outcom
patient
reli
level
facil
healthcar
need
diseas
diagnosi
level
set
repres
challeng
often
requir
simpl
tool
use
without
skill
personnel
signific
laboratori
physic
infrastructur
world
health
organ
develop
set
criteria
assur
defin
ideal
characterist
pointofcar
poc
test
lowresourc
set
accord
criteria
ideal
test
afford
risk
infect
result
falseneg
sensit
falseposit
specif
userfriendli
rapid
robust
equipmentfre
deliver
popul
need
test
addit
requir
perform
paramet
test
depend
intend
usecas
scenario
individu
patient
case
manag
sensit
multiplex
test
advantag
determin
sourc
nonspecif
symptom
select
appropri
treatment
epidemiolog
standpoint
goal
simpli
reduc
preval
highintens
infect
within
geograph
region
need
quantifi
diseas
burden
outweigh
need
high
analyt
sensit
goal
diseas
elimin
high
analyt
sensit
one
import
paramet
sinc
interrupt
local
transmiss
requir
detect
everi
infect
includ
extrem
lowintens
infect
sensibl
approach
design
develop
poc
diagnost
examin
optim
individu
compon
integr
singl
diagnost
devic
review
defin
compon
diagnost
includ
target
biomark
endogen
indic
diseas
state
often
pathogen
host
protein
carbohydr
nucleic
acid
sequenc
sampl
prepar
allow
biomark
isol
purif
andor
concentr
complex
biolog
matric
molecular
recognit
element
specif
captur
detect
target
biomark
signal
gener
amplif
instrument
signal
readout
simpl
compon
requir
singl
user
step
gener
prefer
lowresourc
level
set
howev
diagnost
technolog
current
deploy
set
lack
appropri
diagnost
resourcelimit
set
lead
tragic
outcom
fortun
emerg
technolog
base
inorgan
chemistri
nanomateri
exploit
potenti
solut
review
focu
inorgan
chemistri
nanomateri
util
compon
poc
diagnost
infecti
diseas
detect
section
describ
inorgan
biomark
associ
infecti
diseas
properti
exploit
diagnost
applic
section
discuss
coordin
chemistri
har
sampl
prepar
protein
biomark
enrich
poc
test
section
detail
critic
advanc
inorgan
chemistri
nanomateri
signal
gener
probe
allow
field
poc
diagnost
rapidli
progress
section
provid
overview
fielddeploy
instrument
incorpor
fundament
inorgan
chemistri
discuss
section
poc
diagnosi
infecti
diseas
final
section
discuss
emerg
trend
use
inorgan
chemistri
nanomateri
nucleic
acid
detect
point
care
biomark
quantifi
characterist
diseas
state
measur
accur
reproduc
vast
major
biomark
target
infecti
diseas
fall
three
main
categori
pathogen
genet
materi
protein
carbohydr
antigen
produc
pathogen
human
host
respons
presenc
infect
pathogenspecif
antibodi
inorgan
marker
infecti
diseas
far
less
common
bioorgan
counterpart
metalbas
biomark
uniqu
properti
leverag
innov
diagnost
strategi
illustr
follow
two
exampl
hemozoin
often
call
malaria
pigment
biominer
produc
parasit
reli
hematophagi
primari
sourc
nutrient
hemozoin
first
describ
malaria
parasit
plasmodium
falciparum
centuri
ago
produc
plasmodium
speci
erythrocyt
life
stage
malaria
parasit
digest
host
hemoglobin
acid
digest
food
vacuol
sourc
amino
acid
breakdown
one
hemoglobin
molecul
releas
four
molecul
heme
ferriprotoporphyrin
ix
fe
iii
ppix
highli
toxic
parasit
plasmodium
spp
lack
function
heme
oxygenas
activ
parasit
remov
free
heme
crystal
insolubl
inert
hemozoin
crystal
crystal
accumul
parasit
cours
erythrocyt
life
cycl
matur
schizont
ruptur
hemozoin
releas
circul
rapidli
taken
phagocyt
heme
detoxif
pathway
produc
hemozoin
crucial
malaria
parasit
surviv
therefor
hemozoin
indic
presenc
plasmodia
parasit
make
attract
biomark
malaria
detect
structur
hemozoin
crystal
consist
reciproc
fe
iii
ppix
dimer
link
coordin
central
ferric
ion
carboxyl
group
one
propion
moieti
protoporphyrin
iv
dimer
assembl
chain
hydrogen
bond
second
propion
porphyrin
side
chain
network
crosslink
dimer
held
togeth
via
interact
figur
result
anisotrop
rectangular
crystal
uniqu
magnet
optic
photoacoust
properti
one
properti
hemozoin
paramagnet
deriv
unpair
electron
central
fe
iii
ion
like
paramagnet
substanc
hemozoin
magnet
moment
thu
attract
magnet
gradient
presenc
extern
appli
magnet
field
paramagnet
hemozoin
leverag
malaria
diagnosi
sever
way
first
magnet
properti
exploit
separ
purif
concentr
infect
red
blood
cell
irbc
blood
sampl
use
highgradi
extern
magnet
field
irbc
separ
first
perform
heidelberg
et
al
purpos
vaccin
develop
though
time
method
describ
applic
small
blood
volum
requir
apparatu
difficult
access
sinc
avail
highfield
perman
magnet
electromagnet
substanti
improv
time
requir
magnet
separ
irbc
reduc
commerci
avail
system
well
custommad
microfluid
devic
use
enrich
irbc
whole
blood
sampl
analysi
microscopi
three
group
explor
detect
hemozoin
base
fact
paramagnet
materi
decreas
nuclear
magnet
reson
nmr
transvers
relax
time
water
phenomenon
leverag
magnet
reson
imag
mri
contrast
agent
karl
et
al
first
demonstr
hemozoin
could
detect
base
decreas
though
parasitemia
greater
parasitesmicrolit
order
magnitud
greater
detect
limit
commerci
rapid
diagnost
test
sever
year
later
peng
et
al
kong
et
al
develop
lowcost
homemad
micromagnet
reson
devic
hemozoinbas
malaria
detect
report
detect
limit
less
parasitesmicrolit
use
method
attribut
drastic
improv
use
ultrashort
echo
time
premeasur
centrifug
step
pellet
red
blood
cell
whole
blood
discord
conclus
led
reaction
karl
et
al
respons
peng
et
al
recent
gossuin
et
al
confirm
result
karl
et
al
indic
convent
relaxometri
alon
insuffici
sensit
malaria
detect
find
led
two
hypothes
relat
superior
sensit
measur
peng
et
al
premeasur
centrifug
higherdens
irbc
compar
uninfect
rbc
significantli
enrich
hemozoin
portion
pellet
measur
ultrashort
echo
time
may
allow
probe
proton
macromolecular
proton
may
suscept
presenc
hemozoin
simpl
lowresourc
relaxometrybas
detect
devic
remain
develop
devic
would
ultim
requir
resourc
typic
avail
primari
healthcar
set
lmic
ie
consist
avail
electr
clean
water
howev
studi
highlight
import
advantag
sampl
prepar
enrich
step
develop
sensit
infecti
diseas
diagnost
addit
paramagnet
properti
uniqu
optic
properti
hemozoin
enabl
develop
new
diagnost
tool
malaria
detect
particular
hemozoin
strongli
scatter
absorb
light
latter
characterist
led
remark
develop
microvascular
microscop
mvm
needlefre
vivo
detect
hemozoin
mvm
employ
crosspolar
epiillumin
optic
access
vessel
surfac
skin
green
light
nm
illumin
locat
vessel
red
light
nm
illumin
detect
hemozoin
method
abl
detect
parasitemia
low
mous
model
correspond
approxim
parasitesmicrolit
human
unfortun
lower
parasit
densiti
infect
explor
mvm
abl
differenti
irbc
hemozoincontain
white
blood
cell
persist
circul
week
infect
clear
base
diamet
rel
intens
detect
hemozoin
addit
hemozoin
particl
veloc
could
measur
vivo
figur
potenti
allow
identif
cytoadhes
sequestr
two
phenomena
relat
diseas
sever
though
sensit
analysi
field
test
requir
mvm
repres
promis
noninvas
tool
malaria
detect
particularli
portabl
batterypow
devic
develop
photoacoust
spectroscopi
also
demonstr
potenti
transderm
malaria
detect
photoacoust
pa
hemozoin
detect
requir
excit
intens
light
measur
result
acoust
signal
gener
local
thermal
expans
surround
medium
util
vitro
pa
detect
hemozoin
first
demonstr
balasubramanian
et
al
sinc
shown
short
intens
laser
excit
hemozoin
parasit
local
heat
around
crystal
evapor
surround
medium
creat
transient
nanos
vapor
bubbl
expans
collaps
nanobubbl
enhanc
acoust
detect
techniqu
allow
transderm
malaria
detect
except
sensit
mice
method
also
appli
one
human
patient
high
parasit
densiti
parasitesmicrolit
studi
increas
patient
sampl
size
necessari
determin
true
limit
technolog
magnetoopt
detect
exploit
paramagnet
optic
properti
malari
hemozoin
crystal
rectangular
shape
afford
high
level
magnet
anisotropi
optic
dichroism
techniqu
whole
blood
lyse
whole
blood
insert
magnet
field
orient
paramagnet
crystal
along
appli
field
direct
phenomenon
known
cottonmouton
effect
induc
optic
dichroism
across
dispers
crystal
result
detect
chang
transmitt
modul
polar
light
nm
figur
appli
patient
whole
blood
sampl
diagnost
sensit
specif
magnetoopt
detect
competit
rapid
diagnost
test
pcr
though
eas
use
encourag
poc
applic
particular
model
simul
suggest
magnetoopt
detect
hemozoin
could
exploit
develop
noninvas
probe
capabl
measur
transmitt
polar
light
fingertip
similar
magnetoopt
strategi
employ
fluctuat
magnet
field
measur
chang
amplitud
transmitt
shown
potenti
mous
model
evalu
diagnost
sensit
specif
human
sampl
need
recent
commerci
magnetoopt
devic
malaria
detect
base
hemozoin
demonstr
promis
field
evalu
detect
clinic
parasit
densiti
low
parasitesmicrolit
hemex
health
addit
techniqu
use
detect
malari
hemozoin
includ
flow
cytometri
laserdesorpt
mass
spectrometri
raman
spectroscopi
strategi
highli
sensit
requir
expens
resourceintens
instrument
typic
prevent
use
district
hospit
set
local
health
outpost
field
set
howev
instrument
becom
compact
robust
afford
similar
technolog
detail
section
implement
field
set
could
becom
feasibl
importantli
hemozoin
synthes
hematophag
parasit
infect
human
includ
schistosoma
echinostoma
opisthorchi
trematod
well
blood
feed
insect
rhodniu
boophilu
despit
produc
addit
parasit
hemozoin
yet
use
diagnost
biomark
nonmalari
pathogen
import
note
aforement
hemozoinbas
malari
detect
strategi
hemozoin
origin
trematod
would
produc
posit
signal
particularli
import
consid
regard
fals
posit
test
sinc
geograph
distribut
malaria
overlap
schistosoma
addit
confound
signal
origin
hematophag
parasit
hemozoin
biomark
present
uniqu
challeng
malaria
diagnosi
first
biocryst
present
much
lower
concentr
ring
stage
compar
later
trophozoit
schizont
stage
erythrocyt
cycl
thu
magnet
enrich
malaria
diagnosi
strategi
base
hemozoin
could
miss
earli
stage
infect
potenti
result
falseneg
addit
phagocyt
cell
ingest
irbc
hemozoin
releas
circul
schizont
ruptur
hemozoincontain
white
blood
cell
shown
persist
circul
day
parasit
clearanc
persist
lead
falseposit
result
hemozoinbas
malari
diagnost
unless
algorithm
distinguish
pigmentcontain
white
blood
cell
irbc
devis
one
develop
aforement
work
burnett
et
al
despit
challeng
research
continu
develop
innov
techniqu
malaria
detect
use
hemozoin
biomark
implement
method
requir
care
design
cost
equip
reduct
mind
addit
rigor
field
evalu
schistosom
egg
common
biomark
schistosomiasi
detect
produc
adult
schistosoma
worm
pair
resid
intestin
bladder
deposit
vessel
gut
wall
mani
egg
becom
perman
lodg
intestin
liver
bladder
urogenit
system
lead
chronic
inflamm
system
tissu
damag
howev
matur
egg
excret
urin
fece
allow
parasit
continu
transmiss
cycl
egg
distinct
speci
distinguish
morpholog
differ
includ
overal
egg
shape
round
oval
spine
posit
extent
filament
coat
featur
observ
microscopi
gold
standard
schistosomiasi
diagnosi
void
egg
schistosoma
speci
contain
matur
miracidia
within
rel
imperm
eggshel
dens
biopolym
composit
schistosoma
eggshel
studi
sinc
inorgan
compon
eggshel
investig
jone
et
al
demonstr
presenc
iron
schistosoma
japonicum
eggshel
figur
group
use
induct
coupl
plasma
mass
spectrometri
icpm
energi
dispers
spectroscopi
ed
provid
evid
iron
local
eggshel
although
element
character
techniqu
provid
specif
inform
oxid
state
organ
iron
present
group
found
eggshel
contain
mgkg
dri
weight
fe
make
nearli
iron
found
intact
egg
year
jone
studi
teixeira
et
al
set
increas
sensit
microscopi
schistosoma
detect
use
magnet
microparticl
enrich
egg
fecal
sampl
accomplish
stool
sampl
suspend
water
repeatedli
siev
wash
sediment
incub
magnet
particl
bound
schistosoma
egg
techniqu
egg
concentr
dub
helmintex
method
demonstr
sensit
katokatz
current
recommend
sampl
prepar
method
schistosom
diagnosi
field
set
initi
hypothes
helmintex
method
biotinyl
lectin
would
bind
carbohydr
surfac
schistosoma
mansoni
egg
streptavidinco
magnet
bead
could
bind
biotinlectinegg
complex
use
extern
magnet
egg
could
isol
concentr
detect
microscopi
howev
control
experi
demonstr
follow
lectin
necessari
egg
bind
magnet
particl
nonmagnet
latex
particl
bind
mansoni
egg
egg
alon
migrat
extern
magnet
figur
observ
coupl
discoveri
iron
local
eggshel
led
hypothes
presenc
extern
magnet
field
paramagnet
bead
act
weak
bar
magnet
enabl
attract
iron
shell
egg
karl
et
al
probe
iron
distribut
magnet
properti
schistosom
eggshel
elucid
mechan
helmintex
method
studi
found
iron
local
pore
eggshel
schistosom
egg
demonstr
moder
paramagnet
behavior
howev
egg
move
magnet
field
paramagnet
particl
bound
parasit
egg
absenc
magnet
field
suggest
mechan
bind
magnet
origin
author
also
found
japonicum
egg
bound
microparticl
mansoni
lead
hypothesi
filament
outer
structur
egg
promin
japonicum
compar
mansoni
egg
provid
strong
nonmagnet
adhes
base
mani
rel
weak
van
der
waal
interact
separ
studi
candido
et
al
also
observ
japonicum
egg
bound
microparticl
mansoni
group
use
poisson
analysi
found
two
distinct
popul
within
speci
high
affin
group
low
affin
group
affin
determin
number
microparticl
bound
visibl
edg
singl
egg
interestingli
magnitud
high
affin
valu
similar
two
speci
fraction
egg
high
affin
group
japonicum
greater
mansoni
collect
result
suggest
differ
filament
microspin
two
speci
fulli
explain
mechan
eggmicroparticl
bind
addit
work
candido
et
al
open
mani
question
answer
could
greatli
inform
optim
helmintex
method
instanc
physiochem
differ
high
low
affin
egg
group
biolog
differ
two
group
egg
matur
surfac
antigen
express
karl
et
al
candido
et
al
studi
perform
egg
isol
liver
infect
mice
two
egg
popul
appear
urin
fece
infect
human
two
type
magnet
microspher
use
ensur
helmintex
method
captur
egg
type
present
sampl
question
answer
care
systemat
given
greater
number
microspher
bound
egg
high
affin
group
popul
separ
use
extern
magnet
field
differ
strength
eggmicroparticl
bind
mechan
popul
could
interrog
determin
solut
properti
eg
ph
salt
surfact
chelat
block
protein
etc
requir
interrupt
interact
addit
function
microspher
way
systemat
vari
zeta
potenti
hydrophob
could
determin
role
physiochem
properti
play
bind
studi
crucial
helmintex
method
aim
determin
infect
intens
use
quantit
egg
enrich
particularli
import
schistosomiasi
surveil
morbid
control
campaign
aim
quantifi
reduc
preval
highintens
infect
helmintex
method
origin
idea
iron
eggshel
schistosom
could
serv
handl
magnet
enrich
schistosoma
egg
sensit
detect
field
set
helmintex
method
alreadi
shown
improv
sensit
katokatz
elucid
optim
true
bind
mechan
could
lead
even
impact
method
diagnos
lowintens
schistosomiasi
infect
metalbas
sampl
prepar
techniqu
enrich
biomark
concentr
improv
sensit
diagnost
deliv
biomark
test
strategi
appli
exist
assur
diagnost
test
later
flow
assay
lfa
easiest
way
deliv
biomark
test
would
add
larger
sampl
volum
mani
lfa
accommod
larg
sampl
volum
sever
reason
first
limit
bed
volum
porou
paper
substrat
physic
limit
amount
liquid
test
hold
second
increas
number
interf
molecul
result
increas
sampl
volum
could
caus
nonspecif
cross
reaction
test
molecular
recognit
element
eg
antibodi
third
color
biolog
matric
whole
blood
increas
background
signal
decreas
user
abil
distinguish
posit
neg
result
metalbas
sampl
prepar
techniqu
mitig
shortcom
allow
concentr
target
larg
volum
sampl
smaller
testcompat
volum
moreov
metalbas
sampl
prepar
also
remov
target
origin
complex
biolog
matrix
decreas
potenti
nonspecif
crossreact
lowcost
simpl
robust
method
repres
power
tool
usecas
scenario
improv
sensit
need
elimin
campaign
section
discuss
metal
coordin
chemistri
leverag
simpl
sampl
prepar
method
applic
poc
diagnost
coordin
chemistri
defin
chemistri
metal
atom
ion
form
complex
one
ligand
util
coordin
biomark
particular
affin
metal
ion
signific
illustr
capac
isol
protein
via
immobil
metal
affin
chromatographi
imac
techniqu
involv
conjug
variou
ligand
solid
support
matrix
agaros
cellulos
silica
ligand
act
lewi
base
chelat
metal
ion
high
affin
fix
metal
ion
serv
lewi
acid
coordin
immobil
ligand
specif
amino
acid
residu
protein
biomark
amino
acid
affin
toward
metal
ion
vari
histidin
demonstr
particularli
high
affin
toward
metal
ion
format
interact
leverag
isol
biomark
complex
biolog
matrix
separ
target
competit
elut
concentr
smaller
volum
suitabl
poc
diagnost
test
choic
chelat
ligand
critic
imac
protein
separ
effici
ligand
fix
metal
ion
solid
support
modul
metalprotein
bind
base
number
conform
chelat
site
multitud
ligand
vari
coordin
number
employ
imac
platform
contain
trident
tetradent
chelat
although
bident
pentadent
option
exist
figur
tetradent
nitrilotriacet
acid
nta
trident
iminodiacet
acid
ida
two
common
commerci
ligand
mani
compani
also
develop
proprietari
structur
talon
nipenta
varieti
chelat
ligand
mani
possess
differ
coordin
number
make
imac
tunabl
benefici
tailor
chemistri
differ
diagnost
applic
guid
pearson
theori
numer
metal
ion
ligand
combin
exploit
imac
borderlin
acid
co
ni
cu
zn
predomin
display
vari
level
affin
specif
determin
ion
optim
given
isol
often
depend
protein
question
ni
ii
nta
one
wide
util
ligand
combin
imac
applic
recent
thorough
investig
compar
dival
metal
molecular
recognit
capabl
lack
bauer
et
al
fill
void
conduct
systemat
investig
affin
malari
biomark
histidinerich
protein
function
biosensor
solid
phase
resin
co
ni
cu
zn
frequent
detect
target
malari
rapid
diagnost
test
possess
uniqu
primari
structur
contain
histidin
make
ideal
histidinerich
target
author
use
biolay
interferometri
bli
optic
biosensor
techniqu
determin
kinet
constant
eg
k
k
bind
variou
metal
author
found
co
zn
exhibit
fastest
bind
kinet
highest
k
highest
bind
affin
lowest
k
bli
biosensor
imac
complex
incorpor
loos
solid
phase
resin
zn
ii
nta
result
fastest
complet
bind
per
mole
dival
metal
also
allow
effici
elut
upon
addit
imidazol
metal
select
bind
elut
behavior
evalu
varieti
ligand
solid
support
select
zn
ii
ida
resin
integr
pipet
tip
format
enabl
direct
captur
spike
lyse
blood
sampl
fielddeploy
sampl
isol
concentr
tool
display
signal
enhanc
commerci
rapid
diagnost
test
figur
studi
demonstr
optim
imac
metalligand
combin
particular
applic
critic
effici
biomark
captur
elut
initi
bind
tight
prevent
biomark
elut
compet
ligand
eg
imidazol
weak
attain
suboptim
biomark
enrich
imac
adapt
varieti
solid
support
platform
agaros
gel
rigid
silica
particl
although
mani
platform
becom
wellestablish
research
tool
emerg
novel
materi
figur
coordin
imac
ligand
ida
nta
ted
dival
metal
bind
histidin
residu
protein
co
ni
cu
zn
predominantli
util
applic
ida
iminodiacet
acid
trident
ligand
coordin
number
remain
three
coordin
site
metal
avail
bind
two
histidin
residu
water
molecul
nta
nitrilotriacet
acid
tetradent
ligand
coordin
number
two
coordin
site
histidin
residu
bind
ted
tri
carboxymethyl
ethylen
diamin
pentadent
ligand
coordin
number
one
remain
coordin
site
protein
bind
al
enabl
imac
chemistri
new
applic
exampl
wang
et
al
polymer
polyhedr
oligomer
silsesquioxan
posss
microns
particl
nanos
pore
subsequ
function
ida
charg
cu
materi
use
specif
captur
hemoglobin
rich
surfaceexpos
histidin
residu
incub
test
solut
cu
ii
ida
function
materi
enabl
select
captur
hemoglobin
versu
protein
without
access
histidin
residu
develop
novel
materi
use
principl
imac
demonstr
nanomateri
modifi
molecular
recognit
histidinerich
protein
modifi
nanomateri
potenti
incorpor
poc
diagnost
framework
biomark
captur
imacfunction
cellulos
membran
could
provid
anoth
excel
option
sampl
prepar
lowresourc
set
given
membran
alreadi
hold
establish
place
laboratori
research
tool
could
readili
incorpor
fieldfriendli
paper
fluidic
devic
opitz
et
al
util
commerci
idafunction
cellulos
charg
zn
platform
separ
influenza
viru
particl
cultur
lysat
initi
metal
screen
saw
zn
charg
membran
separ
particl
significantli
higher
affin
metal
test
author
postul
influenza
hemagglutinin
glycoprotein
particular
strain
studi
influenza
viru
puerto
contain
histidinerich
zn
coordin
sequenc
subunit
repeat
configur
subunit
part
capsid
structur
contribut
higher
overal
bind
avid
although
imacbas
method
separ
viru
particl
cell
cultur
develop
improv
effici
laboratorybas
research
difficult
imagin
extend
concept
simpl
sampl
prepar
method
increas
sensit
influenza
rapid
test
appli
develop
protocol
diagnost
test
would
requir
feasibl
test
clinic
patient
sampl
ideal
result
design
integr
devic
sampl
prepar
viru
detect
imacfunction
cellulos
membran
present
uniqu
advantag
relat
materi
eas
incorpor
paperbas
diagnost
format
usabl
lowresourc
poc
set
magnet
particl
hold
number
advantag
solid
imac
support
increas
surfac
area
particl
provid
increas
avail
chemic
reactiv
function
independ
respons
paramagnet
particl
extern
appli
magnet
field
enabl
activ
mix
proven
especi
use
microfluid
applic
magnet
suscept
also
allow
easi
manipul
particl
target
biomark
bound
permit
biomark
isol
concentr
downstream
detect
multistep
protocol
would
otherwis
reli
heavili
laboratori
techniqu
filtrat
centrifug
column
chromatographi
easili
perform
use
magnet
bead
handheld
extern
magnet
asid
chromatograph
capabl
magnet
particl
employ
signal
gener
label
detect
induct
magnetoresist
sensor
applic
discuss
detail
section
magnet
particl
thu
repres
promis
vehicl
imac
chemistri
lowresourc
set
wright
research
group
recent
demonstr
imacfunction
magnet
bead
potenti
improv
commerci
poc
diagnost
sensit
malaria
captur
largevolum
whole
blood
sampl
dilut
lyse
p
falciparumspik
sampl
via
chelat
ni
ii
nta
surfac
flowthrough
devic
captur
malari
biomark
via
zn
ii
ida
chelat
histidin
residu
devic
incorpor
silica
resin
solid
phase
function
zn
ii
ida
pipet
tip
enabl
rapid
captur
whole
blood
sampl
use
principl
imac
subsequ
addit
imidazol
high
concentr
competit
elut
zn
ii
ida
resin
smaller
volum
small
volum
sampl
deposit
onto
commerci
avail
rapid
diagnost
test
enhanc
sensit
detect
poc
set
adapt
permiss
ref
copyright
american
institut
physic
commerci
avail
magnet
particl
use
special
design
extract
cassett
handheld
magnet
particl
guid
stationari
liquid
chamber
separ
surfacetens
valv
wash
sampl
remov
background
purifi
magnet
bead
bound
transfer
final
elut
chamber
preload
imidazol
releas
biomark
result
theoret
concentr
factor
due
transfer
blood
sampl
elut
chamber
extract
use
selfcontain
system
author
ad
elut
volum
varieti
commerci
malaria
rapid
diagnost
test
found
signific
signal
enhanc
across
brand
subsequ
studi
group
develop
optim
handheld
easytous
devic
figur
imacfunction
magnet
bead
directli
transfer
sampl
pad
commerci
malaria
later
flow
assay
biomark
elut
imidazolespik
run
buffer
shown
figur
devic
enabl
highli
sensit
detect
ad
user
step
improv
detect
limit
commerci
malaria
test
order
magnitud
minim
ad
cost
per
test
enhanc
sensit
could
make
substanti
differ
malaria
elimin
campaign
reli
detect
treat
infect
individu
includ
lowdens
carrier
one
primari
limit
imac
chemistri
abil
recogn
protein
affin
metal
ion
purif
recombin
protein
cell
cultur
drawback
overcom
via
incorpor
short
hexahistidin
tag
tag
express
protein
sequenc
use
similar
principl
bauer
et
al
develop
platform
targetspecif
antibodi
modifi
tag
combin
imac
magnet
bead
isol
concentr
biomark
biolog
sampl
thu
advantag
imac
biomark
enrich
longer
limit
histidinerich
protein
rather
could
extend
protein
biomark
target
context
malaria
diagnosi
expand
capabl
allow
detect
nonhistidinerich
biomark
plasmodium
lactat
dehydrogenas
pldh
alongsid
benefici
sever
reason
plasmodium
ldh
essenti
parasit
surviv
conserv
across
speci
malaria
known
infect
human
wherea
produc
p
falciparum
addit
test
fail
account
parasit
infect
contain
pf
gene
delet
increas
preval
worldwid
final
shown
persist
host
circul
day
success
treatment
pldh
clear
within
h
parasit
clearanc
dual
assay
distinguish
resolv
activ
p
falciparum
infect
reason
bauer
et
al
employ
imacbas
tag
antibodi
approach
concentr
pldh
larg
volum
sampl
parasitespik
whole
blood
util
commerci
avail
imac
magnet
bead
dual
captur
system
coordin
directli
co
ii
ntafunction
surfac
magnet
bead
pldh
bound
use
antipldh
antibodi
figur
follow
isol
biomark
taggedantibodypldh
complex
simultan
elut
imidazol
appli
whole
blood
sampl
spike
p
falciparum
parasit
strategi
result
nearli
improv
limit
detect
commerci
lfa
uniqu
platform
demonstr
imacbas
biomark
enrich
ment
limit
histidinerich
protein
could
expand
virtual
biomark
commerci
avail
antibodi
one
challeng
associ
employ
antibodyimac
concentr
strategi
biomark
remain
bound
antibodi
detect
step
antibodi
use
sampl
prepar
potenti
block
target
bind
via
overlap
epitop
steric
effect
molecular
recognit
element
employ
downstream
assay
lead
falseneg
result
challeng
address
design
diagnost
tag
antibodi
downstream
detect
element
bind
orthogon
epitop
target
furthermor
tag
molecular
recognit
element
aptam
could
use
place
tag
antibodi
aptam
short
singlestrand
nucleic
acid
sequenc
secondari
structur
afford
high
bind
affin
compar
antibodi
aptam
smaller
may
target
uniqu
epitop
potenti
allow
innov
sampl
prepar
strategi
univers
appli
coordin
chemistrybas
sampl
prepar
technolog
enabl
signific
improv
sensit
pointofcar
diagnost
enhanc
sensit
sever
exampl
improv
whole
order
magnitud
make
strong
case
use
technolog
elimin
campaign
previous
biomark
enrich
strategi
incorpor
lowresourc
diagnost
restrict
format
test
imacbas
chemistri
describ
section
repres
innov
yet
simpl
solut
open
door
develop
poc
diagnost
incorpor
sampl
prepar
sampl
prepar
method
present
section
increas
total
number
assay
step
method
design
tandem
diagnost
devic
util
detect
move
forward
humancent
devic
design
integr
sampl
prepar
detect
element
permit
next
gener
poc
diagnost
develop
minim
user
step
improv
sensit
inorgan
metal
complex
nanoparticl
instrument
develop
target
reagent
diseaseassoci
dna
protein
cell
biomed
applic
includ
develop
metallodrug
enzym
inhibitor
phototherm
photodynam
therapi
agent
mri
contrast
vivo
bioimag
proteincel
imag
agent
uniqu
optic
electrochem
magnet
catalyt
properti
also
enabl
use
signal
modal
diagnost
section
focus
applic
metalbas
signal
gener
probe
detect
protein
biomark
point
care
summar
tabl
biomark
tabl
signal
gener
method
detect
pathogen
nucleic
acid
via
metalbas
signal
gener
probe
discuss
detail
section
first
describ
inorgan
complex
util
photoluminesc
electrochem
electrochemiluminesc
applic
respect
subsequ
detail
essenti
bioconjug
chemistri
permit
nanoparticl
function
molecular
recognit
element
gener
use
diagnost
reagent
discuss
variou
class
function
nanoparticl
use
poc
diagnost
assay
lastli
consid
catalyt
properti
metalloenzym
metal
nanoparticl
util
signal
amplif
poc
diagnost
infecti
diseas
broad
array
properti
result
ligand
coordin
metal
leverag
signal
product
varieti
diagnost
format
inorgan
coordin
compound
valuabl
signal
gener
probe
due
low
molecular
weight
tunabl
uniqu
catalyt
photophys
properti
compound
use
photoluminesc
ie
fluoresc
phosphoresc
electrochem
electrochemiluminesc
ecl
sens
platform
signal
gener
method
tradeoff
regard
easeofus
interpret
well
complex
instrument
requir
measur
signal
output
design
lowresourc
diagnost
tradeoff
must
evalu
base
usecas
scenario
test
environ
collect
consider
better
inform
develop
inorgan
complex
suitabl
particular
signal
gener
method
luminesc
photoluminesc
inorgan
complex
possess
uniqu
properti
offer
sever
advantag
organ
fluorophor
signal
molecul
diagnost
advantag
includ
longliv
phosphoresc
signific
stoke
shift
emiss
tuneabl
via
ligand
composit
longliv
phosphoresc
benefici
spectral
distinct
autofluor
figur
tag
coupl
antipldh
antibodi
via
sulfosmcc
allow
chelat
tag
antibodi
co
ii
ntafunction
magnet
bead
remain
site
bead
surfac
unoccupi
antibodi
permit
coordin
directli
bead
surfac
subsequ
biomark
captur
imidazol
ad
elut
histag
antibodi
pldh
complex
adapt
ref
larg
stoke
shift
metal
complex
also
result
improv
sensit
selfquench
signal
molecul
minim
addit
tunabl
emiss
metal
complex
enabl
use
signal
transduc
wherebi
ligand
exchang
reaction
induc
chang
emiss
spectra
correl
biomark
concentr
date
cyclometal
complex
ir
iii
commonli
util
photoluminesc
signal
gener
probe
ligand
cyclometal
ir
iii
complex
eg
deproton
demonstr
strong
effect
significantli
increas
energi
mc
metalcent
excit
state
ie
ligand
field
stabil
energi
give
rise
nonradi
decay
pathway
result
excit
electron
complex
preferenti
popul
mlct
metaltoligand
charg
transfer
excit
state
oppos
mc
excit
electron
undergo
intersystem
cross
subsequ
phosphoresc
mixtur
lc
ligandcent
mlct
excit
state
figur
high
phosphoresc
quantum
yield
larg
stoke
shift
make
complex
ideal
signal
gener
davi
et
al
design
switchon
ir
iii
detect
probe
select
produc
phosphoresc
signal
presenc
malari
biomark
cyclometal
ir
iii
complex
ir
ppi
h
poorli
luminesc
absenc
howev
aqua
ligand
displac
histidin
residu
biomarkerdepend
mlct
lc
phosphoresc
signal
produc
figur
similar
principl
imac
chemistri
discuss
section
approach
capit
chelat
histidin
repeat
inorgan
coordin
compound
assay
design
aptli
show
tunabl
luminesc
ir
iii
complex
could
har
signal
transduct
demonstr
ligand
exchang
reaction
phosphoresc
signal
could
correl
biomark
concentr
addit
ir
iii
complex
display
signific
stoke
shift
nm
make
less
prone
selfquench
effect
decreas
sensit
associ
organ
fluorophor
counterpart
studi
also
incorpor
ir
iii
probe
imac
magnet
beadbas
biomark
isol
detect
assay
recombin
detect
limit
nm
although
less
sensit
elisa
enzymelink
immunosorb
assay
concentr
within
relev
rang
clinic
diagnosi
malaria
moreov
beadbas
assay
could
complet
less
h
wherea
tradit
elisa
requir
h
current
assay
format
would
permit
applic
betterequip
laboratori
develop
cyclometal
ir
iii
probe
could
excit
detect
element
lfa
antibodi
test
line
howev
photoluminesc
detect
mechan
depend
exist
histidinerich
biomark
applic
particular
strategi
limit
generaliz
platform
use
photoluminesc
ir
iii
probe
develop
lin
et
al
detect
interferongamma
inflammatori
cytokin
biomark
immunolog
diseas
hiv
molecular
recognit
detect
assay
use
two
aptam
one
highli
specif
second
guaninerich
nucleic
acid
sequenc
two
aptam
design
partial
complementari
prehybrid
prior
introduct
sampl
contain
presenc
aptam
bound
target
liber
guaninerich
sequenc
introduct
k
ion
induc
format
guanin
quadruplex
subsequ
bound
ir
iii
probe
switchon
luminesc
correl
biomark
concentr
phosphoresc
signal
figur
ir
iii
probe
possess
long
phosphoresc
lifetim
signific
stoke
shift
nm
thu
exhibit
canon
advantag
inorgan
probe
organ
fluorophor
assay
demonstr
adequ
specif
versu
protein
commonli
found
biolog
matric
eg
human
serum
albumin
immunoglobulin
limit
detect
nm
dynam
rang
nm
howev
assay
suffer
reduct
sensit
conduct
cell
extract
attempt
made
complex
biolog
matric
pertin
hiv
diagnosi
eg
blood
urin
saliva
etc
nonetheless
assay
establish
proofofprincipl
use
photoluminesc
cyclometal
ir
iii
complex
detect
probe
hiv
biomark
moreov
assay
format
generaliz
could
appli
virtual
biomark
highaffin
aptam
combin
one
sampl
prepar
strategi
discuss
previous
section
integr
paper
anoth
fieldreadi
substrat
ir
iii
base
detect
strategi
could
produc
robust
sensit
assay
applic
lowresourc
diagnost
set
electrochemistri
electrochemiluminesc
ecl
appli
potenti
rang
potenti
sampl
contain
electroact
inorgan
probe
current
luminesc
measur
output
electrochem
ecl
detect
respect
electrochem
eclbas
assay
combin
molecular
recognit
element
antibodi
aptam
electroact
inorgan
probe
shown
promis
infecti
diseas
detect
particular
inorgan
lowspin
complex
ir
iii
ru
ii
well
hemin
ferriprotoporphyrin
ix
util
develop
electrochemicaland
eclbas
probe
electrochemistri
ecl
signal
gener
strategi
wellsuit
develop
poc
diagnost
larg
due
capabl
miniatur
low
cost
simplic
rapid
timetoresult
high
sensit
aptli
demonstr
develop
paperbas
electrochem
diagnost
platform
often
term
microfluid
paperbas
electrochem
devic
electrochem
paper
analyt
devic
epad
test
util
paper
assay
substrat
combin
instrument
amen
lowresourc
set
cell
phone
detect
incorpor
exist
electrochemicaland
eclbas
assay
format
could
result
robust
highli
sensit
infecti
diseas
diagnost
would
impact
diseas
surveil
case
manag
robust
sensit
diagnost
need
electrochemistri
diagnost
assay
electrochem
detect
commonli
consist
threeelectrod
system
work
electrod
often
gold
carbon
modifi
molecular
recognit
element
biomark
captur
counter
electrod
typic
platinum
refer
electrod
commonli
satur
calomel
electrod
ag
agcl
electrod
format
incub
biolog
sampl
electrochem
cell
initi
result
captur
biomark
work
electrod
introduct
biomarkerspecif
inorgan
probe
support
electrolyt
subsequ
applic
electrochem
method
eg
cyclic
voltammetri
squar
wave
voltammetri
differenti
puls
voltammetri
amperometri
etc
result
signific
current
product
work
electrod
current
correl
biomark
concentr
regard
infecti
diseas
biomark
detect
hemin
ir
iii
complex
ru
ii
complex
util
electrochem
probe
hemin
ferriprotoporphyrin
ix
fe
contain
porphyrin
deriv
mimic
enzymat
activ
horseradish
peroxidas
catalyz
reduct
h
see
section
enzymat
activ
enhanc
hemin
incorpor
gquadruplex
aptam
zhang
et
al
develop
electrochem
assay
detect
hivassoci
util
hemin
key
compon
signal
gener
mechan
dna
construct
conjug
gold
work
electrod
dna
construct
contain
gquadruplex
sequenc
specif
hemin
aptam
gquadruplex
aptam
prehybrid
hairpin
author
util
function
work
electrod
assay
util
two
aptam
first
aptam
green
prehybrid
gquadruplex
aptam
blue
addit
sampl
result
captur
first
aptam
liber
gquadruplex
aptam
underw
structur
switch
form
guanin
tetrad
upon
introduct
k
ion
gquadruplex
specif
cyclometal
ir
iii
perform
cyclic
voltammetri
sampl
contain
monitor
reduct
h
could
correl
concentr
figur
sampl
contain
aptam
bound
open
hairpin
subsequ
allow
hemin
bind
gquadruplex
potenti
sweep
catalyz
reduct
h
hemingquadruplex
dnazym
produc
cathod
current
proport
concentr
sampl
assay
yield
detect
limit
nm
dynam
rang
nm
thu
perform
similarli
luminesc
assay
develop
lin
et
al
section
though
author
demonstr
specif
assay
versu
nontarget
protein
bsa
igg
report
whether
assay
could
perform
complex
matric
significantli
compromis
assay
perform
rigor
test
assay
biolog
matric
therefor
need
demonstr
robust
assay
miao
colleagu
synthes
implement
ir
iii
complexbas
electrochem
probe
detect
figur
first
gold
work
electrod
function
molecular
beacon
mb
contain
aptam
well
sequenc
partial
complementari
second
oligonucleotid
strand
h
absenc
portion
mb
complementari
h
hybrid
hairpin
structur
bound
aptam
h
sequenc
freed
avail
hybrid
complement
h
develop
ir
iii
probe
bound
major
minor
groov
h
doubl
helix
oxid
reduct
ligand
via
differenti
puls
voltammetri
dpv
result
concentrationdepend
current
thu
correl
electrochem
signal
presenc
target
biomark
electrochem
assay
detect
limit
fm
dynam
rang
pm
could
conduct
sampl
human
serum
importantli
assay
yield
improv
limit
detect
compar
two
previous
discuss
assay
detect
larg
due
signal
amplif
result
groovebind
numer
ir
iii
probe
h
doubl
helix
provid
multipl
signalgener
element
everi
one
biomark
bound
present
form
assay
could
appli
primari
healthcar
set
util
electrochem
workstat
requir
train
personnel
signific
laboratori
resourc
howev
portabl
electrochem
detect
system
one
describ
section
could
allow
highli
sensit
assay
appli
poc
set
electrochemiluminesc
similar
electrochem
assay
ecl
system
employ
work
electrod
function
targetspecif
molecular
recognit
element
potenti
manipul
similar
voltammetr
measur
howev
ecl
appli
potenti
also
gener
excit
state
ecl
probe
produc
luminesc
upon
relax
canon
probe
eclbas
detect
ru
bpi
complex
deriv
thereof
use
extens
develop
eclbas
sensor
infecti
diseas
detect
diagnost
assay
ecl
ru
bpi
occur
primarili
coreact
mechan
coreact
commonli
ntripropylamin
tpra
figur
coreact
ecl
simultan
figur
hemin
dnazymebas
catalyt
assay
electrochem
detect
thiolat
dna
construct
conjug
au
work
electrod
dna
construct
consist
gquadruplex
aptam
specif
hemin
purpl
aptam
blue
aptam
dna
construct
prehybrid
hairpin
presenc
aptam
bound
open
hairpin
hemin
ad
bound
gquadruplex
form
dnazym
could
catalyz
reduct
h
reduct
produc
current
proport
concentr
sampl
analog
mlct
state
popul
absorpt
photon
triplet
excit
state
undergo
phosphoresc
decay
ground
state
allow
luminesc
detect
target
biomark
variou
mechan
electrogener
luminesc
excit
state
coreact
ecl
proven
advantag
develop
diagnost
assay
permit
measur
obtain
aqueou
solvent
matric
one
platform
detect
infecti
diseas
pioneer
yoon
et
al
use
immunoliposom
encapsul
ecl
signal
gener
probe
liposom
equip
maleimid
handl
synthes
method
load
ru
bpi
maleimidefunction
liposom
conjug
thiolactiv
antibodi
specif
target
antigen
result
immunoliposom
serv
targetspecif
reagent
contain
ecl
probe
could
releas
applic
deterg
sd
triton
author
incorpor
ru
bpi
load
immunoliposom
membran
strip
test
detect
legionella
antigen
strip
test
contain
follow
compon
nitrocellulos
membran
impregn
legionella
antigen
glass
fiber
pad
presoak
sd
screenprint
electrod
could
interfac
ecl
analyz
immunoliposom
incub
buffer
solut
contain
legionella
antigen
sampl
solut
allow
wick
nitrocellulos
strip
antigen
sampl
antigen
embed
nitrocellulos
compet
bind
immunoliposom
posit
sampl
immunoliposom
bound
legionella
antigen
solut
migrat
past
nitrocellulos
strip
glass
fiber
pad
sd
glass
fiber
pad
lyse
immunoliposom
releas
ru
bpi
detect
coreact
ecl
correl
antigen
concentr
figur
assay
could
complet
min
limit
detect
ngml
compar
tradit
later
flow
assay
test
requir
addit
user
manipul
step
preincub
sampl
immunoliposom
addit
coreact
etc
assay
also
depend
benchtop
ecl
analyz
therefor
illsuit
level
healthcar
set
current
format
howev
novel
platform
demonstr
capabl
ecl
detect
target
antigen
show
ru
bpi
load
immunoliposom
could
util
amplifi
signal
variat
load
immunoliposom
platform
sinc
appli
detect
influenza
viru
biomark
hemagglutinin
recent
zhou
et
al
develop
eclbas
immunosensor
hiv
biomark
associ
earli
stage
infect
detect
promot
earlier
intervent
hiv
case
detect
probe
assay
nanocomposit
consist
gold
nanoparticledecor
graphen
prgo
au
ru
bpi
dope
silica
nanoparticl
rusio
figur
gold
nanoparticlemodifi
glassi
carbon
electrod
gce
function
antibodi
molecular
recognit
second
antibodi
conjug
prgo
au
rusio
nanocomposit
use
detect
element
sandwich
form
electrod
coreact
ntripropylamin
tpa
ad
produc
ecl
signal
mechan
previous
discuss
prgo
au
rusio
nanocomposit
offer
sever
benefit
system
name
increas
surfac
area
ecl
reaction
increas
rate
electron
transfer
sio
nanoparticl
permit
greater
ru
bpi
load
gold
nanoparticlegraphen
composit
increas
load
ru
bpi
dope
sio
nanoparticl
author
contend
aspect
led
increas
concentr
eclprob
work
electrod
surfac
ultim
improv
assay
review
detect
limit
lod
pgml
linear
rang
addit
author
demonstr
antigen
could
detect
dilut
human
serum
remain
challeng
develop
luminesc
electrochem
ecl
assay
incorpor
inorgan
complex
thorough
valid
complex
biolog
matric
clinic
sampl
aforement
luminesc
assay
rigor
evalu
biolog
sampl
import
consider
develop
luminesc
assay
high
background
result
presenc
interfer
biolog
sampl
biofoul
electrod
known
challeng
develop
electrochem
sensor
well
although
sever
previous
mention
electrochem
ecl
assay
test
dilut
biolog
matric
thorough
evalu
biolog
matrix
affect
limit
detect
still
need
howev
issu
interfer
biofoul
could
potenti
address
integr
detect
platform
metalbas
sampl
prepar
strategi
discuss
section
result
robust
sensit
assay
inorgan
complex
demonstr
promis
detect
infecti
diseas
biomark
luminesc
electrochem
ecl
detect
platform
discuss
section
capit
uniqu
properti
result
interplay
ligand
metal
center
howev
inorgan
complex
rare
use
standalon
probe
biomark
detect
instead
inorgan
nanoparticl
emerg
predomin
probe
infecti
diseas
diagnost
integr
inorgan
complex
nanomateri
repres
potenti
avenu
develop
next
gener
detect
probe
one
interest
nanomateri
incorpor
inorgan
complex
organ
framework
mof
nanos
network
organ
ligand
metal
ioncomplex
connect
point
ligand
provid
function
handl
conjug
molecular
recognit
element
signalgener
metal
complex
instal
connect
point
encapsul
within
network
recent
electrochem
aptasensor
develop
contain
aptamerconjug
mof
specif
recognit
detect
variou
protein
small
molecul
target
moreov
two
complex
discuss
section
ir
ppi
ru
bpi
alreadi
incorpor
mof
sens
imag
applic
integr
molecular
recognit
element
mof
architectur
applic
ir
iii
ru
ii
base
mof
could
expand
includ
luminesc
electrochem
ecl
detect
infecti
diseas
biomark
recent
expans
nanochemistri
drastic
influenc
mani
area
scienc
diagnost
inorgan
nanoparticl
becom
ubiquit
detect
element
numer
platform
eg
colorimetr
luminesc
electrochem
thermal
etc
distinct
class
nanoparticl
possess
uniqu
advantag
caveat
diagnost
set
usecas
scenario
determin
applic
detect
method
turn
direct
nanoparticl
use
order
appli
inorgan
nanoparticl
diagnost
reagent
targetspecif
molecular
recognit
element
ie
antibodi
aptam
oligonucleotid
probe
must
function
nanoparticl
surfac
section
first
review
bioconjug
reaction
nanoparticl
character
method
section
list
reaction
meant
exhaust
rather
highlight
essenti
coval
affinitybas
coupl
strategi
nanoparticl
bioconjug
survey
variou
type
nanoparticl
appli
detect
infecti
diseas
potenti
applic
point
care
section
function
character
nanoparticl
develop
nanoparticl
detect
reagent
target
toward
biomark
requir
conjug
molecular
recognit
element
surfac
type
conjug
often
requir
linker
facilit
attach
nanoparticl
surfac
chemistri
employ
coupl
molecular
recognit
element
nanoparticl
surfac
diagnost
applic
gener
reli
key
bioconjug
reaction
similar
use
planar
solid
support
howev
smaller
size
regim
nanoparticl
significantli
influenc
reaction
kinet
nanoparticl
surfac
therefor
bioconjug
reaction
must
optim
given
class
size
nanoparticl
coval
coupl
given
preval
carboxyl
primari
amin
nanoparticl
surfac
molecular
recognit
element
one
common
bioconjug
strategi
gener
function
nanoparticl
detect
probe
format
amid
bond
convent
reagent
form
amid
bond
nanoparticl
surfac
dimethylamino
propyl
carbodiimid
edc
produc
activ
ester
subsequ
react
primari
amin
howev
alon
edcactiv
ester
react
slowli
amin
often
lead
hydrolysi
product
inhibit
amid
coupl
reason
edc
usual
pair
sulfonh
nhydroxysuccinimid
ester
improv
stabil
activ
ester
intermedi
sulfonh
esteractiv
intermedi
readili
react
primari
amin
nucleophil
form
stabl
amid
linkag
figur
edcsulfonh
coupl
use
gener
antibodyand
nucleic
acidnanoparticl
conjug
diagnost
detect
probe
due
intrins
abund
primari
amin
antibodi
readili
conjug
carboxyl
nanoparticl
without
need
initi
derivat
edc
coupl
imidazol
enabl
conjug
ethylen
diamin
phosphat
group
nucleic
acid
yield
oligonucleotid
coupl
carboxyl
particl
quantum
dot
magnet
nanoparticl
polymer
latex
particl
found
applic
poc
diagnost
commonli
equip
carboxyl
amin
surfac
enabl
conjug
via
edc
coupl
quantum
dot
convent
stabil
dihydrolipo
acid
dhla
deriv
variou
copolym
instal
carboxyl
surfac
magnet
nanoparticl
coat
carboxylatecontain
polym
enabl
function
primari
aminecontain
biomolecul
altern
quantum
dot
magnet
nanoparticl
coat
silica
shell
derivat
carboxyl
amin
function
group
silica
nanoshel
form
via
condens
silica
oxid
monom
tetraethyl
orthosil
teo
apt
yield
surfac
aminopropylsilanol
figur
surfac
silica
subsequ
coupl
molecular
recognit
element
via
edc
addit
suppli
function
group
bioconjug
silica
encapsul
nanoparticl
provid
biocompat
protect
core
materi
degrad
make
suitabl
strategi
prepar
diagnost
nanoparticl
detect
probe
signific
reaction
class
gener
nanoparticl
detect
probe
bioconjug
thiol
present
either
molecular
recognit
element
nanoparticl
surfac
thiolat
nucleic
acid
prepar
method
aminefunction
nucleic
acid
except
cystamin
use
place
ethylen
diamin
addit
disulfid
reduc
dithiothreitol
dtt
give
oligonucleotid
probe
hand
antibodi
gener
contain
free
thiol
therefor
either
thiolat
often
traut
reagent
cleav
interchain
disulfid
via
dtt
papain
gener
thiol
subsequ
bioconjug
nanoparticl
surfac
coupl
thiolat
biomolecul
nobl
metal
nanoparticl
refer
gold
silver
nanoparticl
convent
done
via
coordin
coval
dativ
bond
lone
pair
sulfur
atom
form
stabl
linkag
directli
nanoparticl
surfac
figur
altern
thiolcontain
affin
reagent
nanoparticl
coupl
via
maleimidederiv
heterobifunct
crosslink
agent
commonli
sulfosmcc
nmaleimidomethyl
thiol
react
chemic
review
maleimid
function
sulfosmcc
form
stabl
thioether
wherea
nhsester
compon
sulfosmcc
react
primari
amin
molecular
recognit
element
nanoparticl
surfac
figur
photochem
crosslink
click
chemistri
also
util
produc
nanoparticlebas
detect
probe
photosensit
function
group
includ
phenyl
azid
diazirin
gener
reactiv
nitren
carben
respect
upon
exposur
uv
light
allow
insert
bond
figur
photochem
agent
integr
heterobifunct
crosslink
sulfonhslcdiazirin
conjug
nanoparticl
molecular
recognit
element
click
chemistri
gener
refer
bioorthogon
reaction
high
yield
minim
side
product
mild
condit
common
click
reaction
conjug
azid
alkyn
presenc
cu
catalyst
figur
mani
class
click
reaction
coupl
nanoparticl
molecular
recognit
element
predomin
affinitybas
conjug
strategi
nanoparticl
function
system
biotin
small
molecul
bind
extraordinarili
high
affin
k
bacteri
protein
streptavidin
streptavidin
approxim
kda
tetramer
protein
permit
stoichiometri
biotin
streptavidin
gener
streptavidin
ad
nanoparticl
surfac
via
passiv
adsorpt
heterobifunct
crosslink
sulfosmcc
common
method
biotinyl
molecular
recognit
element
coupl
sulfonhsbiotin
nh
peg
n
biotin
primari
amin
although
bioconjug
gener
easi
peg
n
spacer
may
includ
optim
depth
streptavidin
bind
pocket
well
low
rel
solubl
biotin
nanoparticl
character
character
nanoparticl
conjug
essenti
determin
success
extent
particl
function
drastic
affect
particl
perform
diagnost
format
sever
character
techniqu
applic
develop
detect
probe
diagnost
spectroscopi
one
commonli
use
method
biomoleculefunction
nanoparticl
given
simplic
applic
detect
nucleic
acid
protein
particl
size
distribut
assess
use
dynam
light
scatter
dl
transmiss
electron
microscopi
tem
function
group
character
nanoparticl
surfac
evalu
nmr
andor
infrar
ir
spectroscopi
analyt
method
tradeoff
respect
cost
sensit
time
analysi
complex
sampl
prepar
howev
mani
techniqu
offer
complementari
inform
use
combin
ensur
extens
character
inorgan
nanoparticl
detect
probe
princip
concern
associ
antibodi
modif
decreas
antigenbind
activ
result
overfunction
variabl
region
antibodi
optim
bioconjug
reaction
minim
effect
achiev
balanc
suffici
nanoparticl
coupl
effici
retent
antigen
bind
extent
antibodi
modif
monitor
function
groupspecif
chromophor
detect
ellman
reagent
freethiol
detect
haba
acid
biotin
detect
also
biosensor
techniqu
surfac
plasmon
reson
spr
quartz
crystal
microbal
qcm
bli
employ
assess
impact
modif
bind
affin
antigen
decreas
target
affin
also
origin
suboptim
load
antibodi
nucleic
acid
nanoparticl
surfac
insuffici
coverag
may
lead
nonspecif
bind
interfer
wherea
overload
nanoparticl
molecular
recognit
element
result
steric
effect
decreas
target
bind
simpl
absorbancebas
supernat
assay
measur
antibodi
nucleic
acid
concentr
nanoparticl
function
reaction
give
estim
element
surfac
densiti
aid
determin
nanoparticl
surfac
satur
straightforward
natur
procedur
make
popular
strategi
character
extent
function
nanoparticl
conjug
use
infecti
diseas
diagnost
bioconjug
chemistri
attach
molecular
recognit
element
nanoparticl
surfac
key
compon
transform
nanoparticl
interest
signal
properti
function
reagent
employ
diagnost
assay
character
nanoparticl
postfunction
critic
ensur
optim
signal
downstream
diagnost
applic
sever
class
function
nanoparticl
util
develop
poc
diagnost
infecti
diseas
choic
depend
usecas
scenario
desir
signal
output
section
describ
fundament
principl
poc
applic
class
nanoparticl
nobl
metal
nanoparticl
gold
nanoparticl
aunp
silver
nanoparticl
agnp
collect
refer
nobl
metal
nanoparticl
possess
mani
uniqu
properti
make
advantag
probe
signal
gener
infecti
diseas
diagnost
nobl
metal
nanoparticl
display
vivid
color
observ
nake
eye
due
surfac
plasmon
reson
spr
phenomenon
spr
illustr
figur
occur
incom
photon
strike
nanoparticl
surfac
gener
dipol
caus
electron
oscil
ie
surfac
plasmon
frequenc
reson
frequenc
incom
light
visibl
light
fulfil
reson
condit
nobl
metal
nanoparticl
give
rise
larg
molar
extinct
coeffici
order
cm
visibl
wavelength
moreov
nanoparticl
color
max
manipul
control
size
figur
nobl
metal
nanoparticl
also
easili
function
antibodi
aptam
oligonucleotid
probe
afford
specif
target
biomolecul
altogeth
qualiti
made
nobl
metal
nanoparticl
frequent
choic
colorimetr
label
diagnost
assay
design
interpret
nake
eye
import
note
limit
discuss
aunp
sinc
use
diagnost
sens
applic
extens
review
given
vast
literatur
exist
aunp
applic
elect
focu
applic
agnp
signal
gener
probe
infecti
diseas
diagnosi
similar
aunp
local
spr
agnp
capit
upon
chemic
review
review
develop
colorimetr
assay
infecti
diseas
protein
nucleic
acid
biomark
addit
conjug
fluoresc
probe
eg
fam
agnp
surfac
well
intrins
luminesc
agnp
permit
develop
luminescencebas
assay
high
agnp
conduct
also
exploit
electrochem
detect
nucleic
acid
lastli
surfaceenhanc
raman
spectroscopi
ser
agnp
employ
direct
detect
malariainfect
red
blood
cell
signific
light
scatter
agnp
high
specif
raman
signatur
colorimetr
detect
use
nanoparticl
paperbas
assay
wide
implement
method
signal
readout
primari
healthcar
set
fact
success
later
flow
assay
credit
part
nanoparticlebas
detect
system
allow
visual
interpret
result
end
user
use
function
agnp
colorimetr
detect
probe
paperbas
diagnost
infecti
diseas
report
protein
nucleic
acid
biomark
exampl
yen
et
al
employ
agnp
multiplex
later
flow
assay
detect
dengu
yellow
fever
ebola
viru
author
synthes
nm
agnp
visual
detect
orang
red
green
respect
due
sizedepend
spr
shift
nanoparticl
particular
size
specif
function
distinct
targetspecif
antibodi
associ
one
virus
allow
detect
three
diseas
singl
assay
figur
detect
limit
biomark
found
ngml
within
clinic
relev
rang
diseas
higher
publish
method
multiplex
diagnost
assay
critic
discrimin
febril
ill
point
care
allow
select
appropri
treatment
cours
colorimetr
agnp
aggreg
assay
also
reli
sizedepend
spr
agnp
aggreg
decreas
distanc
nanoparticl
result
interparticl
spr
produc
larg
redshift
absorpt
distinct
color
chang
visibl
unaid
eye
reaction
mechan
classifi
either
crosslink
noncrosslink
crosslink
assay
agnp
function
molecular
recognit
element
cap
ligand
stabil
nanoparticl
solut
addit
sampl
target
biomark
result
crosslink
function
nanoparticl
drastic
decreas
nano
review
distanc
produc
spectral
shift
agnp
aggreg
assay
format
implement
detect
infecti
diseas
protein
nucleic
acid
biomark
howev
best
knowledg
crosslinkingbas
agnp
aggreg
yet
employ
paper
diagnost
lowresourc
platform
noncrosslink
aggreg
assay
nanoparticl
either
aggreg
stabil
molecular
recognit
element
electrostat
adsorb
nanoparticl
surfac
subsequ
addit
sampl
contain
diagnost
target
either
disrupt
promot
nanoparticl
stabil
produc
observ
color
chang
exampl
teengam
et
al
develop
noncrosslink
aggreg
assay
use
agnp
multiplex
visual
detect
middl
east
respiratori
syndrom
coronaviru
mycobacterium
tuberculosi
human
papillomaviru
oligonucleotid
microfluid
paper
analyt
devic
assay
lack
sensit
requir
detect
pathogen
nucleic
acid
howev
sensit
nucleic
acid
diagnost
incorpor
amplif
techniqu
eg
pcr
requir
extens
resourc
infrastructur
avail
betterequip
laboratori
nonetheless
use
agnp
aggregationassay
enabl
multiplex
visual
detect
three
differ
nucleic
acid
biomark
format
could
applic
primari
healthcar
set
take
advantag
intrins
fluoresc
agnp
kurdekar
et
al
develop
fluoresc
immunoassay
detect
util
streptavidinco
agnp
detect
probe
use
standard
wellplat
immunoassay
format
adsorb
antibodi
captur
sampl
biotinyl
detect
antibodi
streptavidinconjug
fluoresc
agnp
subsequ
ad
gener
fluoresc
signal
correl
concentr
assay
success
detect
standard
spike
plasma
well
present
hivposit
patient
plasma
sampl
moreov
cross
reactiv
observ
sampl
hivneg
hbvor
hcvposit
limit
detect
assay
pgml
order
magnitud
higher
previous
discuss
assay
section
discrep
could
explain
lack
signal
amplif
fluoresc
agnpbas
immunoassay
current
format
fluoresc
agnp
immunoassay
amen
resourcelimit
primari
healthcar
set
howev
fluoresc
agnp
could
employ
later
flow
assay
format
combin
portabl
fluoresc
reader
allow
implement
point
care
quantum
dot
qd
quantum
dot
qd
semiconductor
nanocryst
luminesc
conduct
properti
make
advantag
detect
probe
infecti
diseas
diagnost
canon
qd
consist
combin
element
group
ii
vi
group
iii
v
rang
size
nm
small
size
qd
absorb
photon
gener
excit
electron
conduct
band
posit
charg
hole
valenc
band
semiconductor
figur
distanc
separ
pair
confin
less
diamet
nanocryst
result
particl
box
behavior
known
quantum
confin
result
quantum
confin
qd
emiss
wavelength
increas
nanoparticl
size
increas
thu
qd
emiss
tune
via
sizecontrol
synthesi
figur
qd
exhibit
absorpt
across
broad
spectrum
yet
emiss
spectra
narrow
tunabl
bandwidth
particularli
use
multiplex
detect
diseas
biomark
addit
qd
demonstr
increas
biocompat
photost
quantum
yield
semiconduct
properti
compar
tradit
organ
fluorophor
render
qd
advantag
signal
gener
probe
diagnost
escherichia
coli
cholera
fluoresc
assay
laboratori
resourcelimit
set
function
qd
qdload
microparticl
util
fluoresc
probe
protein
nucleic
acid
biomark
surfac
qd
function
antibodi
antigen
protein
detect
oligonucleotid
probe
target
dna
detect
use
bioconjug
strategi
discuss
section
thorough
evalu
bioconjug
qd
reader
direct
number
review
goldman
et
al
pioneer
earliest
use
antibodyfunction
qd
fluoresc
detect
probe
author
util
affinitybas
coupl
chemistri
ie
well
electrostat
interact
charg
moieti
function
antibodi
metal
surfac
cdsezn
quantum
dot
system
found
simpl
reproduc
robust
method
qd
bioconjug
two
function
qd
success
util
multiplex
fluoresc
assay
cholera
toxin
staphylococc
enterotoxin
b
earli
work
exploit
narrow
emiss
profil
enhanc
quantum
yield
qd
antigen
detect
laid
groundwork
develop
enhanc
fluorescencebas
diagnost
varieti
target
build
upon
previou
work
klostranec
et
al
construct
multiplex
fluorescencebas
microfluid
devic
detect
hiv
hepat
b
hepat
c
antibodi
util
antigenfunction
qd
barcod
particl
two
type
cdsezn
qd
synthes
load
polystyren
bead
vari
ratio
result
three
distinct
qd
barcod
particl
qd
barcod
particl
coval
bound
diseasespecif
antigen
via
edc
coupl
assay
employ
sandwich
format
diseasespecif
antibodi
captur
antigenfunction
qd
barcod
particl
fluorophoreconjug
alexafluor
antihuman
antibodi
use
detect
presenc
target
antibodi
narrow
peak
width
qd
emiss
enabl
detect
antibodyconjug
fluorophor
nm
indic
presenc
target
antibodi
well
qd
nm
yellow
nm
red
ratio
red
yellow
signal
intens
allow
barcod
identif
determin
three
target
antibodi
present
figur
detect
limit
antibodi
correl
three
diseas
picomolar
rang
improv
compar
commerci
elisa
assay
enabl
multiplex
sensit
detect
infecti
diseas
biomark
microfluid
platform
employ
author
requir
extens
user
manipul
complex
instrument
analysi
would
viabl
higher
level
healthcar
set
given
improv
sensit
assay
adapt
techniqu
handheld
fluorimet
cell
phoneadapt
fluoresc
devic
could
potenti
allow
deploy
primari
healthcar
lowresourc
set
benefit
strategi
biomark
signal
barcod
signal
fluorescencebas
result
multiplex
detect
platform
simplifi
compar
assay
differ
detect
scheme
biomark
barcod
author
hypothes
barcod
combin
theoret
possibl
use
approach
due
narrow
distinct
fluoresc
peak
width
gener
differ
qd
particl
allow
even
greater
multiplex
howev
hypothes
approach
caution
highli
multiplex
assay
suscept
crossreact
therebi
reduc
diagnost
specif
individu
assay
qdload
particl
also
function
antibodi
detect
protein
biomark
infecti
diseas
recent
hu
et
al
develop
later
flow
assay
util
antibodyco
polymer
particl
nm
load
qd
nm
aunp
nm
detect
ebola
viru
ebov
glycoprotein
report
probe
author
dub
dual
signal
readout
nanospher
rn
enabl
detect
ebov
glycoprotein
either
visual
via
aunp
fluoresc
via
qd
emiss
character
rn
reveal
dozen
aunp
adsorb
hundr
qd
embed
per
everi
one
antibodyco
polymer
particl
figur
panel
b
thu
everi
one
biomark
arrest
test
line
significantli
signal
review
moieti
permit
sensit
detect
addit
two
set
antibodyfunction
rn
fabric
use
lfa
streptavidinconjug
biotinconjug
rn
applic
sampl
streptavidinconjug
rn
sampl
pad
result
migrat
sampl
rn
test
line
format
antibodi
sandwich
test
line
subsequ
biotinconjug
rn
ad
bound
streptavidinco
rn
enhanc
signal
base
high
affin
streptavidin
interact
author
util
lfa
detect
either
ebov
glycoprotein
whole
virion
spike
sampl
assay
demonstr
broad
dynam
rang
span
order
magnitud
detect
aunp
limit
detect
visual
inspect
ngml
qd
fluoresc
signal
use
detect
limit
improv
ngml
figur
panel
c
fluoresc
detect
assay
order
magnitud
sensit
commerci
brand
rapid
test
ebov
glycoprotein
moreov
fluoresc
signal
could
quantit
imag
process
softwar
readili
avail
smartphon
though
author
util
benchtop
fluorimet
qd
excit
emiss
use
smartphon
adapt
handheld
fluorimet
dedic
fluoresc
later
flow
reader
could
enabl
measur
point
care
sensit
dual
signal
readout
provid
versatil
platform
could
employ
number
usecas
scenario
morbid
control
primari
concern
visual
detect
aunp
would
suffic
sensit
quantit
measur
need
surveil
intervent
manag
elimin
campaign
fluoresc
capabl
detect
probe
could
exploit
howev
given
usecas
scenario
like
one
signal
readout
modal
need
consequ
addit
cost
implement
dual
signal
rn
use
singl
signal
visual
fluoresc
rn
would
suffic
need
consid
nonetheless
assay
demonstr
quantum
dot
could
incorpor
test
readili
deploy
primari
healthcar
set
though
rigor
field
evalu
valid
assay
would
necessari
clinic
use
signific
advanc
use
qdbase
detect
method
infecti
diseas
biomark
complex
instrument
requir
detect
quantum
dot
often
still
barrier
implement
point
care
develop
smartphonebas
devic
current
enabl
detect
fluoresc
label
qd
point
care
fluoresc
assay
demonstr
capac
multiplex
narrow
emiss
profil
demonstr
qd
potenti
continu
expans
multiplex
like
lie
qdbase
fluoresc
assay
given
import
detect
comorbid
coinfect
discrimin
febril
ill
qdbase
technolog
repres
platform
potenti
make
signific
impact
point
care
lanthanid
chelatedop
nanoparticl
nanoparticl
dope
lanthanid
chelat
advantag
detect
label
owe
larg
stoke
shift
sharp
emiss
peak
stabl
luminesc
long
fluoresc
lifetim
biocompat
later
flow
assay
format
particl
often
function
targetspecif
antibodi
embed
conjug
pad
test
like
qd
detect
lanthanid
chelatedop
nanoparticl
requir
addit
instrument
particl
excit
measur
emiss
despit
need
addit
equip
particl
attract
label
poc
diagnost
enabl
highli
sensit
biomolecul
detect
context
elimin
surveil
particular
infecti
diseas
ad
sensit
provid
lanthanid
chelatedop
nanoparticl
could
allow
detect
lowintens
infect
would
otherwis
miss
except
lanthanum
lanthanid
fblock
element
orbit
gradual
fill
atom
number
increas
orbit
larg
shield
chemic
environ
fill
shell
lanthanid
similar
chemic
properti
exampl
common
oxid
state
aqueou
lanthanid
ion
ion
luminesc
though
lanthanid
greater
quantum
yield
other
due
larg
energi
gap
lowest
emiss
energi
level
highest
sublevel
ground
state
size
energi
gap
increas
lanthanid
ion
becom
less
prone
lower
energi
nonradi
decay
process
result
greater
quantum
yield
eu
commonli
util
lanthanid
label
later
flow
assay
ideal
energi
gap
nondegener
emiss
state
ground
state
f
j
conveni
emiss
visibl
region
consequ
eu
focu
section
europium
iii
strongli
luminesc
excit
involv
forbidden
electr
dipol
ff
transit
low
absorpt
cross
section
howev
overcom
ion
coordin
sensit
structur
organ
ligand
simplifi
jablonski
diagram
luminesc
process
eu
chelat
depict
figur
ligand
absorb
excit
energi
transfer
triplet
state
via
intersystem
cross
isc
next
energi
transfer
one
j
level
eu
intern
convers
iet
emiss
occur
energi
level
f
j
level
addit
sensit
chelat
ligand
also
promot
luminesc
shield
eu
aqueou
quench
effect
allow
coupl
biomolecul
polymer
materi
chelat
ligand
typic
absorb
uv
nm
subsequ
eu
emiss
occur
nm
ligand
usual
contain
chromophor
portion
eg
pyridin
salicyl
phenanthrolin
coumarin
pyrazol
triphenylen
quinolon
chelat
structur
base
multident
polyacid
macrocycl
eg
edta
tetracyclin
also
employ
ligand
eu
chelat
dye
incorpor
nanoparticl
function
targetspecif
molecular
recognit
element
use
later
flow
assay
later
flow
assay
employ
eu
chelat
use
commerci
avail
particl
often
superior
due
monodispers
qualiti
control
standard
major
commerci
avail
eu
chelat
later
flow
label
nm
carboxylor
streptavidindecor
polystyren
particl
readili
avail
larg
vendor
thermofish
expedeon
ltd
eu
chelat
easili
adsorb
polymer
eg
polystyren
nanoparticl
base
hydrophob
interact
polym
organ
chelat
ligand
complex
exampl
huhtinen
et
al
found
simpli
incub
nm
polystyren
particl
eu
chelat
dipicolin
acid
deriv
ligand
result
chelat
per
nanoparticl
repres
densiti
approxim
chelatesnm
al
found
similarli
high
densiti
approxim
chelatesnm
chelatesparticl
nm
commerci
avail
particl
thu
biomolecul
bound
later
flow
format
thousand
associ
eu
chelat
produc
signal
result
highli
sensit
measur
advantag
eu
chelateload
polystyren
nanoparticl
label
later
flow
assay
demonstr
yeo
et
al
develop
sensit
later
flow
assay
detect
avian
influenza
subtyp
viru
virus
highli
pathogen
outbreak
china
mortal
rate
roughli
estim
hospit
patient
laboratoryconfirm
infect
current
laboratorybas
molecular
test
requir
differenti
subtyp
avian
influenza
viral
infect
thu
need
rapid
test
perform
point
care
author
approach
problem
develop
evalu
panel
subtypespecif
monoclon
antibodi
hemagglutinin
influenza
best
antibodi
pair
determin
subtypespecif
later
flow
assay
construct
europiumchel
gold
nanoparticl
aunp
conjug
use
benchtop
timeresolv
fluoresc
reader
author
found
detect
limit
eu
chelatebas
test
better
aunpbas
test
addit
develop
eu
base
test
perform
better
commerci
avail
test
detect
influenza
nucleoprotein
enhanc
gold
particl
impress
although
given
high
densiti
chelat
per
nanoparticl
surpris
larger
enhanc
achiev
one
possibl
explan
could
effici
molecular
recognit
element
adsorpt
two
type
nanoparticl
addit
avian
influenza
eu
chelateembed
polymer
nanoparticl
employ
detect
e
coli
hepat
b
procalcitonin
host
marker
bacteri
infect
sever
commerci
platform
base
particl
develop
well
includ
sofia
influenza
ab
test
quidel
inc
aqcar
chlamydia
trf
test
medisensor
inc
extens
evalu
literatur
high
sensit
assay
deriv
high
number
eu
chelat
embed
polymer
nanoparticl
also
use
timeresolv
fluoresc
measur
one
primari
disadvantag
use
luminesc
probe
label
later
flow
assay
high
autofluoresc
biolog
sampl
assay
compon
occur
excit
emiss
wavelength
similar
probe
fluoresc
interfer
later
flow
read
caus
high
background
lead
lowsensit
measur
howev
lanthanid
chelat
overcom
effect
fluoresc
lifetim
sever
order
magnitud
longer
convent
fluoresc
materi
microsecond
millisecond
compar
nanosecond
allow
use
timeresolv
measur
sampl
excit
puls
uv
light
emiss
signal
collect
time
delay
order
ns
given
time
period
delay
collect
emit
signal
shortliv
autofluoresc
biolog
assay
compon
exclud
measur
intens
delay
luminesc
slightli
decay
initi
signal
output
chelat
measur
cycl
improv
signaltonois
cours
uniqu
instrument
requir
timeresolv
measur
make
fielddeploy
technic
challeng
though
current
avail
benchtop
devic
could
allow
measur
district
clinic
laboratori
recent
paterson
et
al
develop
promis
smartphonebas
platform
timeresolv
luminesc
measur
could
allow
pointofcar
measur
base
eu
chelat
particl
howev
lengthi
ms
timedelay
employ
devic
compat
persist
luminesc
nanophosphor
crystallin
sral
eu
dy
particl
polymer
eu
chelat
nanoparticl
primari
materi
employ
lanthanidelabel
later
flow
assay
particl
present
disadvantag
larg
size
tendenc
swell
caus
aggreg
aqueou
solut
addit
sinc
coval
bound
polym
eu
chelat
leach
particl
silica
particl
avoid
problem
one
exampl
xia
et
al
develop
later
flow
assay
hepat
b
detect
use
eu
chelateload
silica
nanoparticl
synthes
particl
author
reli
iter
method
involv
silica
condens
teo
surfaceamin
use
aptm
coval
function
chelat
ligand
particl
load
eu
process
repeat
five
time
achiev
high
densiti
eu
chelat
result
nm
nanoparticl
contain
remark
chelatesparticl
correspond
densiti
roughli
eu
chelatesnm
time
greater
commerci
avail
polymer
particl
particl
function
oxid
dextran
serv
hydrophil
linker
free
amin
moieti
antihepat
b
surfac
antigen
hbsag
specif
antibodi
coupl
surfac
via
reduct
amin
aldehyd
group
synthesi
character
particl
use
label
tradit
format
later
flow
assay
hbsag
measur
signal
strip
illumin
uv
lamp
imag
use
digit
camera
signal
intens
determin
use
imag
analysi
adob
photoshop
unlik
previou
exampl
present
imag
techniqu
take
advantag
long
fluoresc
lifetim
eu
chelat
howev
even
without
timeresolv
measur
ment
detect
limit
lfa
found
pg
ml
hbsag
better
similarli
format
goldbas
later
flow
assay
studi
valid
analyz
clinic
serum
sampl
use
develop
eu
chelatebas
later
flow
assay
well
quantit
elisa
two
method
concord
sampl
analyz
similar
sensit
thu
develop
method
repres
innov
tool
diagnosi
hepat
b
provid
suffici
sensit
compar
clinic
method
order
implement
assay
directli
point
care
two
modif
necessari
assay
optim
fieldfriendli
wholeblood
specimen
mobil
phonebas
detect
strategi
implement
lanthanid
chelatebas
nanoparticl
probe
promis
avenu
develop
highli
sensit
later
flow
assay
similar
fluoresc
probe
instrument
remain
primari
barrier
implement
eu
chelat
nanoparticl
point
care
howev
optic
devic
miniatur
becom
afford
probe
could
becom
commonplac
among
rapid
test
infecti
diseas
upconvert
phosphor
nanoparticl
upconvert
phosphor
ucp
nanoparticl
repres
uniqu
excit
report
technolog
bioassay
unlik
typic
fluoresc
label
ceram
nanoparticl
dope
rare
earth
element
absorb
lowenergi
ir
radiat
emit
higherenergi
visibl
light
ucp
often
superior
convent
colorimetr
fluoresc
report
number
reason
first
high
antistok
shift
ir
visibl
occur
natur
thu
inher
autofluoresc
typic
associ
biolog
sampl
assay
compon
interfer
ucp
measur
second
ucp
signal
highli
stabl
photobleach
allow
indefinit
storag
repetit
analysi
singl
test
especi
use
confirm
field
result
central
laboratori
third
assay
easili
multiplex
distinct
particl
absorb
ir
excit
energi
emit
wavelength
defin
dopant
final
optic
detect
ucp
particl
offer
inher
boost
analyt
sensit
visual
detect
gold
ucp
particl
detect
test
line
later
flow
strip
approxim
gold
particl
need
visual
detect
increas
sensit
make
ucp
particl
attract
label
diagnost
test
employ
surveil
elimin
campaign
resourcelimit
set
sinc
would
enabl
detect
lowintens
asymptomat
infect
howev
similar
qd
lanthanidechel
particl
discuss
preced
section
benefit
ucp
particl
must
weigh
addit
cost
resourc
requir
need
detect
instrument
primari
mechan
upconvers
includ
excit
state
absorpt
energi
transfer
cooper
sensit
excit
state
absorpt
absorpt
light
electron
alreadi
excit
state
requir
two
photon
equal
separ
ground
state
first
excit
state
second
excit
state
singl
ion
energi
transfer
upconvers
requir
two
ion
sensit
activ
process
sensit
ion
excit
sequenti
transfer
energi
ground
state
first
excit
state
activ
ion
cooper
sensit
similar
energi
transfer
though
involv
excit
two
sensit
ion
simultan
transfer
energi
activ
ion
upconvers
mechan
includ
photon
avalanch
cross
relax
energi
transfer
upconvers
common
upconvers
mechan
bioassay
report
particl
typic
involv
yb
sensit
excit
nm
rare
earth
er
tm
pr
ho
gd
activ
codop
yttrium
fluorid
yf
yttrium
oxid
yttrium
oxysulfid
sodium
yttrium
fluorid
nayf
crystal
illustr
upconvers
process
two
materi
shown
figur
ucp
util
label
protein
nucleic
acid
target
later
flow
assay
varieti
infecti
diseas
recent
corstjen
et
al
develop
ultrasensit
ucpbas
later
flow
assay
schistosomiasi
detect
schistosoma
circul
anod
antigen
caa
proteoglycan
biomark
wast
product
produc
parasit
caa
present
serum
urin
patient
schistosoma
infect
known
speci
found
correspond
well
worm
burden
clear
soon
success
treatment
develop
later
flow
assay
employ
nm
yb
er
ucp
excit
nm
emit
nm
green
detect
caa
singl
schistosoma
worm
pair
serum
assay
appli
patient
sampl
endem
area
due
superior
sensit
demonstr
much
higher
schistosomiasi
preval
microscopi
serolog
nucleic
acidbas
test
caa
later
flow
assay
format
similar
convent
later
flow
assay
caaspecif
antibodi
print
test
line
antimous
igg
print
control
line
workflow
assay
current
form
howev
differ
typic
fieldreadi
test
first
trichloroacet
acid
tca
extract
perform
urin
serum
sampl
requir
centrifug
step
extract
supernat
combin
run
buffer
anticaafunction
ucp
particl
incub
h
orbit
shaker
later
flow
strip
ad
solut
test
allow
develop
must
dri
complet
least
h
scan
analyz
strip
order
simplifi
prepar
procedur
decreas
number
step
dri
reagent
kit
later
develop
buffer
particl
lyophil
kit
ship
tertiari
lab
south
africa
nearli
sampl
evalu
local
technician
use
kit
caa
elisa
research
found
ucpbas
lfa
success
identifi
lowlevel
infect
caa
elisa
increas
analyt
sensit
assay
corstjen
et
al
ad
spinfilt
concentr
step
sampl
prepar
method
allow
caa
urin
sampl
volum
ml
concentr
addit
later
flow
strip
result
detect
limit
improv
sampl
volum
increas
reach
low
pgml
ml
assay
demonstr
clinic
applic
concentr
step
success
perform
ml
patient
urin
sampl
kenya
highendem
mansoni
china
lowendem
japonicum
import
note
though
sampl
concentr
step
improv
sensit
assay
requir
laboratori
equip
carri
patient
sampl
studi
process
wellequip
laboratori
addit
concentr
step
increas
cost
ultrasensit
caa
assay
though
sampl
pool
could
make
test
costeffect
allow
monitor
worm
burden
subpopul
level
largescal
surveil
ucpbas
ultrasensit
assay
util
field
set
robust
fieldreadi
sampl
prepar
method
need
later
flow
assay
ucp
report
also
develop
detect
protein
marker
infecti
diseas
includ
neurocysticercosi
hiv
addit
ucpbas
multiplex
later
flow
assay
develop
detect
protein
biomark
multipl
infecti
diseas
multiplex
diagnost
typic
consist
one
strip
multipl
test
line
captur
distinct
protein
biomark
format
ucp
crystal
biomark
though
function
targetspecif
antibodi
one
disadvantag
highli
multiplex
assay
singl
strip
potenti
increas
crossreact
nonspecif
bind
could
lead
falseposit
result
mitig
risk
hong
et
al
develop
uniqu
circular
cassett
channel
differ
singleplex
later
flow
assay
use
ucp
particl
report
label
one
unexplor
applic
multiplex
detect
later
flow
assay
use
ucp
particl
ident
excit
differ
emiss
profil
could
particularli
advantag
larg
biomark
multipl
access
epitop
could
provid
addit
clinic
inform
exampl
assay
captur
detect
whole
organ
could
includ
second
ucp
probe
detect
surfac
protein
confer
drug
resist
provid
detect
suscept
result
one
assay
ucp
nanoparticl
also
use
nonlater
flow
diagnost
format
includ
immunohistochemistri
microarray
magnet
bead
assay
plate
immunoassay
though
platform
readili
amen
lowresourc
pointofcar
set
even
later
flow
format
ucp
nanoparticl
present
interest
challeng
field
deploy
clearli
sampl
prepar
method
includ
purif
concentr
amplif
must
adapt
environ
lack
control
laboratori
condit
reli
littl
electr
possibl
handpow
centrifug
batterypow
mixer
develop
ideal
poc
assay
optim
preclud
addit
resourc
anoth
issu
often
unaddress
later
flow
strip
must
complet
dri
optic
measur
analysi
water
also
absorb
nearir
decreas
excit
effici
sensit
typic
protocol
requir
least
h
dri
time
later
flow
assay
develop
long
timetoresult
pointofcar
test
final
detect
ucp
particl
reli
optic
instrument
although
sensit
devic
benchtop
instrument
portabl
batterypow
devic
develop
ucpmodifi
version
qiagen
esequ
later
flow
reader
ucpquant
mani
sampl
prepar
method
describ
section
appli
ucp
later
flow
format
addit
innov
handheld
optic
reader
discuss
section
requir
simpl
adapt
detect
antistok
shift
ucp
particl
clear
advantag
use
ucp
nanoparticl
label
later
flow
assay
includ
inher
low
background
interfer
high
analyt
sensit
innov
sampl
prepar
method
develop
portabl
optic
reader
allow
advantag
exploit
lowresourc
poc
set
magnet
nanoparticl
frequent
use
sampl
prepar
biomark
enrich
magnet
nanoparticl
emerg
promis
label
poc
assay
similar
nobl
metal
nanoparticl
magnet
nanoparticl
easili
function
possess
strong
optic
absorb
led
use
visual
label
later
flow
assay
howev
magnet
properti
also
leverag
detect
advantag
tradit
optic
detect
later
flow
format
first
visual
optic
detect
absorb
fluoresc
particl
employ
signal
surfac
membran
measur
due
opac
membran
typic
nitrocellulos
membran
use
lfa
thick
optic
detect
allow
signal
top
membran
measur
contrast
magnet
measur
perform
regardless
opac
substrat
take
advantag
entir
volum
test
line
later
flow
assay
addit
metaloxid
nanoparticl
highli
stabl
dri
aggreg
influenc
intens
magnet
measur
final
biolog
assay
compon
interfer
magnet
measur
properti
magnet
particl
sizeand
temperaturedepend
iron
oxid
typic
magnetit
maghemit
particl
common
magnet
nanoparticl
employ
diagnost
applic
bulk
materi
ferrior
ferromagnet
thu
retain
magnet
extern
field
appli
hysteresi
reach
maximum
particl
size
decreas
point
materi
becom
singledomain
particl
size
even
reduc
hysteresi
effect
decreas
particl
reach
critic
diamet
brownian
forc
strong
enough
overcom
magnet
forc
thu
small
size
particl
superparamagnet
magnet
moment
particl
align
presenc
extern
magnet
field
revert
back
nonmagnet
state
field
remov
later
flow
format
magnet
nanoparticl
label
targetspecif
molecular
recognit
element
employ
conjug
analyt
detect
superparamagnet
behavior
ideal
particl
appli
label
review
later
flow
assay
lack
magnet
absenc
extern
field
allow
particl
wick
along
strip
without
aggreg
due
magnet
effect
magnet
properti
particl
leverag
label
bound
test
control
line
magnet
nanoparticl
typic
detect
later
flow
assay
base
induct
figur
use
magnetoresist
sensor
induct
format
employ
principl
faraday
law
magnet
particlebas
test
place
oscil
magnet
field
set
induct
coil
absenc
magnet
particl
net
current
induc
coil
zero
howev
particl
present
direct
magnet
moment
oscil
extern
magnet
field
result
measur
net
voltag
induc
across
coil
proport
total
number
particl
test
control
line
contrast
magnetoresist
sensor
base
principl
electr
resist
certain
materi
incorpor
sensor
chang
upon
applic
extern
magnet
field
format
magnet
field
appli
paraor
superparamagnet
detect
element
order
align
magnet
moment
produc
fring
field
magnetoresist
sensor
place
close
enough
particl
detect
fring
field
produc
base
chang
resist
materi
within
sensor
detail
descript
instrument
requir
detect
method
provid
section
magnet
nanoparticl
employ
detect
label
later
flow
assay
protein
wholecel
target
exampl
handali
et
al
develop
two
magnet
particlebas
later
flow
assay
detect
taenia
solium
cestod
preval
around
world
swine
intermedi
host
contamin
undercook
pork
ingest
parasit
develop
tapeworm
human
gut
taeniasi
howev
egg
ingest
larval
stage
infect
human
nervou
system
potenti
form
cyst
brain
sever
form
diseas
call
neurocysticercosi
lead
caus
epilepsi
worldwid
gold
standard
diagnosi
taeniasi
observ
egg
stool
microscopi
though
method
insensit
laborintens
diagnosi
neurocysticercosi
current
requir
ct
scan
brain
technolog
unavail
lowresourc
set
press
need
solium
rapid
diagnost
test
handali
et
al
develop
two
serolog
magnet
beadbas
later
flow
assay
detect
immun
respons
ie
host
antibodi
taeniasisspecif
cysticercosisspecif
antigen
test
one
batch
recombin
antigen
print
test
line
separ
batch
coupl
commerci
avail
carboxyl
superparamagnet
particl
via
edcnh
chemistri
recombin
antigen
test
line
antigen
conjug
magnet
particl
abl
simultan
bind
host
antibodi
sampl
take
advantag
multival
natur
igm
igg
antibodi
later
flow
assay
evalu
use
inductionbas
reader
visual
read
detect
antibodi
serum
sampl
endem
area
nonendem
control
region
figur
found
taeniasisspecif
assay
diagnost
sensit
specif
respect
evalu
magnet
reader
sensit
specif
neurocysticercosi
test
use
magnet
reader
respect
patient
two
viabl
cyst
determin
ct
scan
mri
brain
patient
one
viabl
cyst
assay
identifi
case
neurocysticercosi
indic
burden
infect
great
enough
elicit
immun
respons
despit
decreas
sensit
singlecyst
infect
develop
later
flow
assay
promis
altern
current
gold
standard
assay
speciesspecif
could
use
detect
porcin
cysticercosi
marker
diseas
control
transmiss
one
disadvantag
util
superparamagnet
label
mani
magnet
reader
benchtop
devic
requir
electr
laboratori
set
howev
case
magnet
nanoparticl
could
detect
visual
sensit
ideal
possibl
initi
visual
result
could
appli
field
followup
laboratorybas
measur
assess
visual
neg
assay
handheld
magnet
reader
becom
commonplac
assay
becom
truli
impact
addit
solium
magnet
particl
employ
proteindetect
later
flow
assay
hiv
influenza
whole
celldetect
magnet
particlebas
assay
also
develop
number
target
includ
vibrio
parahemolyticu
listeria
monocytogen
bacillu
anthraci
demonstr
sensit
magnet
particlebas
later
flow
assay
make
promis
altern
tradit
assay
colorimetr
fluoresc
label
howev
current
instrument
discuss
section
limit
util
point
care
one
excit
avenu
yet
explor
infecti
diseas
detect
employ
superparamagnet
nanoparticl
dual
purpos
immunomagnet
biomark
enrich
largevolum
sampl
visual
label
later
flow
assay
ideal
diagnost
would
integr
sampl
prepar
assay
one
devic
develop
combin
effect
target
enrich
magnet
detect
could
lead
highli
sensit
test
capabl
detect
lowdens
infect
one
wide
util
techniqu
improv
sensit
diagnost
signal
amplif
thousand
signal
molecul
gener
everi
one
biomark
molecul
though
numer
method
amplifi
signal
diagnost
assay
use
metalloenzym
one
first
approach
metalloenzym
metalcontain
catalyt
protein
presenc
particular
metal
metal
complex
tertiari
structur
critic
catalyt
turnov
substrat
predomin
metalloenzym
employ
diagnost
alkalin
phosphatas
alp
horseradish
peroxidas
hrp
catalas
high
catalyt
effici
enzym
enabl
rapid
convers
substrat
detect
product
use
crosslink
chemistri
discuss
section
metalloenzym
conjug
antibodi
nucleic
acid
afford
specif
target
biomark
three
primari
enzym
use
metalloenzym
detect
conjug
reli
differ
metal
ion
catalyt
activ
alp
possess
two
zn
ii
ion
one
mg
ii
ion
per
enzym
monom
hydrolyz
phosphat
monoest
convent
substrat
alp
pointofcar
diagnost
applic
bcip
phosphat
nbt
nitro
blue
tetrazolium
dephosphoryl
oxid
bcip
allow
reduct
yellow
nbt
dye
bluepurpl
formazan
precipit
hrp
catalas
hemecontain
monooxygenas
catalyz
reaction
h
elisa
enzymelink
immunosorb
assay
metalloenzymeantibodi
conjug
wide
implement
elisa
detect
protein
biomark
diseas
due
sensit
afford
use
enzym
signal
amplif
well
specif
interact
use
molecular
recognit
despit
high
sensit
elisa
applic
poc
set
limit
sever
factor
signal
readout
elisa
typic
requir
spectrophotomet
unavail
primari
healthcar
set
though
grow
number
portabl
altern
eg
cellphon
handheld
scanner
see
section
elisa
timeconsum
h
demand
extens
sampl
handl
solut
manipul
often
requir
special
train
lastli
lack
thermal
longterm
stabil
metalloenzym
elisa
lead
suboptim
assay
perform
elisa
intrins
depend
metalloenzym
signal
amplif
readout
thu
elisa
usual
limit
wellequip
tertiari
laboratori
mitig
issu
investig
begun
use
paper
elisa
solid
support
increas
likelihood
sensit
assay
could
use
resourcelimit
set
paperbas
elisa
develop
detect
diagnost
marker
hiv
malaria
longterm
stabil
condit
metalloenzym
paper
also
investig
maxim
catalyt
activ
poc
set
paperbas
elisa
seek
address
mani
issu
inhibit
use
elisa
resourcelimit
poc
set
time
result
paperbas
elisa
h
due
compar
smaller
volum
requir
contrast
convent
benchtop
elisa
smaller
reagent
volum
also
significantli
reduc
overal
cost
elisa
cheng
et
al
first
pioneer
method
detect
serum
antibodi
envelop
antigen
alpantibodi
conjug
util
turn
bcipnbt
substrat
purpl
precipit
product
author
use
hydrophil
paper
pattern
hydrophob
photoresist
fabric
test
well
spatial
separ
polystyren
plate
sampl
contain
biomark
ad
paper
elisa
card
place
top
blot
pad
enabl
wick
reagent
test
well
though
assay
boast
faster
time
result
lower
cost
analog
convent
elisa
sensit
paperbas
elisa
decreas
order
magnitud
compar
convent
elisa
format
lathwal
sike
conduct
systemat
investig
sever
signal
amplif
method
paperbas
colorimetr
detect
malari
biomark
investig
multipl
combin
captur
antibodi
immobil
aldehydemodifi
cellulos
experi
follow
detect
system
evalu
hrp
substrat
dab
h
hrp
substrat
tmb
h
alp
substrat
bcip
nbt
ag
deposit
onto
aunp
polymerizationbas
amplif
factor
ie
captur
antibodi
captur
antibodi
load
biomark
detect
antibodi
held
constant
differ
review
observ
assay
presum
direct
result
signal
amplif
system
use
posit
neg
control
evalu
variou
time
point
signal
amplif
method
determin
optim
window
visual
readout
signal
figur
method
optim
time
point
visual
signal
readout
except
hrptmbh
produc
signific
falseposit
signal
color
chang
blue
brown
difficult
interpret
remain
method
combin
hrpdabh
alpbcipnbt
detect
limit
order
magnitud
better
ag
deposit
polymerizationbas
amplif
method
quantifi
rgb
color
intens
portabl
colorimetr
reader
even
cell
phone
could
enabl
use
highli
sensit
metalloenzym
conjug
primari
healthcar
set
advantag
paperbas
elisa
potenti
compromis
instabl
metalloenzym
conjug
sinc
denatur
metalloenzym
lead
poor
turnov
substrat
lower
sensit
reason
notabl
research
effort
devot
optim
longterm
storag
metalloenzym
particularli
hrp
use
microfluid
paper
analyt
devic
twodimension
paper
network
one
method
involv
vacuum
dri
freezedri
enzym
substrat
presenc
trehalos
disaccharid
often
use
cryoprotect
capac
stabil
protein
interact
solvent
form
protect
glass
dri
ramachandran
et
al
use
combin
trehalos
bovin
serum
albumin
bsa
feso
edta
vacuum
dri
hrpconjug
antibodi
malari
biomark
glass
fiber
pad
stabil
hrp
could
store
month
condit
without
signific
loss
catalyt
activ
glass
fiber
pad
contain
reagent
incorpor
detect
lod
ngml
valu
well
within
clinic
relev
concentr
assay
also
demonstr
util
metalloenzym
paperbas
poc
diagnost
provid
signal
amplif
step
rare
present
convent
paper
diagnost
eg
later
flow
assay
advanc
enzym
stabil
combin
simplifi
paperbas
assay
format
could
potenti
allow
elisa
sensit
translat
direct
use
point
care
nanoparticleassist
enzymat
signal
amplif
integr
nobl
metal
nanoparticl
augment
signal
amplif
capabl
metalloenzym
infecti
diseas
diagnost
nanoparticl
serv
surfac
coupl
antibodymetalloenzym
conjug
implement
electrochem
sensor
detect
infecti
diseaseassoci
protein
biomark
zheng
et
al
develop
amperometr
immunosensor
detect
hiv
antigen
employ
standard
sandwich
format
glassi
carbon
electrod
modifi
gold
nanoparticl
allow
immobil
captur
antibodi
hrpconjug
antibodi
use
detect
catalyz
oxid
substrat
hydroquinon
presenc
h
reaction
gener
reduct
current
electrod
surfac
proport
concentr
detect
limit
assay
pgml
similar
assay
previous
discuss
section
assay
robust
human
serum
sampl
spike
serum
sampl
test
contain
concentr
order
magnitud
higher
lod
current
requir
electrochem
workstat
would
limit
assay
applic
higher
level
laboratori
nonetheless
amperometr
method
demonstr
valu
integr
nobl
metal
nanoparticl
metalloenzym
conjug
signal
amplif
diagnosi
infecti
diseas
nobl
metal
nanoparticl
also
util
colorimetr
signal
probe
elisa
detect
protein
biomark
diseas
socal
plasmon
elisa
util
standard
sandwich
assay
format
immobil
captur
antibodi
detect
antibodi
conjug
metalloenzym
howev
oppos
use
convent
metalloenzym
substrat
colorimetr
detect
plasmon
elisa
employ
enzym
kinet
tool
nanoparticl
nucleat
caus
drastic
shift
spr
absorb
spectra
nanoparticl
detect
nake
eye
plasmon
elisa
pioneer
de
la
rica
steven
util
catalaseconjug
detect
antibodi
control
growth
aunp
manner
proport
concentr
hiv
biomark
absenc
biomark
bulk
au
iii
reduc
h
form
stabl
spheric
aunp
appear
red
color
present
sampl
catalaseconjug
figur
redshift
spr
highli
sensit
toward
h
concentr
thu
deplet
h
catalas
present
sampl
allow
sensit
detect
nake
eye
absorb
also
quantifi
use
simpl
spectrophotometr
readout
yield
detect
limit
agml
nearli
order
magnitud
sensit
previous
discuss
detect
method
antigen
author
also
demonstr
plasmon
elisa
could
detect
hivposit
serum
sampl
even
identifi
sampl
hivposit
patient
viral
load
less
copi
ml
remark
sensit
assay
nakedey
detect
provid
necessari
improv
requir
elimin
campaign
activ
case
manag
would
permit
earlier
detect
lead
improv
outcom
hiv
patient
assay
could
particularli
impact
challeng
associ
earli
infant
hiv
diagnosi
lowresourc
set
plasmon
elisa
present
author
still
call
extens
sampl
handl
user
manipul
current
unsuit
primari
healthcar
set
adapt
previous
discuss
enzym
stabil
measur
integr
assay
fieldreadi
format
eg
paperbas
elisa
could
enabl
translat
ultrasensit
fieldreadi
diagnost
hiv
detect
metalloenzym
play
critic
role
signal
amplif
number
assay
enabl
sensit
detect
infecti
diseas
sever
research
effort
aim
translat
sensit
metalloenzymebas
assay
format
paperbas
diagnost
amen
resourcelimit
set
although
issu
enzym
storag
paper
address
certain
extent
longterm
stabil
enzym
remain
concern
poc
diagnost
especi
climat
elev
temperatur
preval
infecti
diseas
numer
method
util
nonenzymat
mean
signal
amplif
elimin
issu
longterm
enzym
storag
altogeth
includ
nanoparticl
act
enzym
mimic
metalbas
method
cover
follow
section
major
signal
amplif
bioassay
enzymebas
sever
interest
metalbas
amplif
strategi
develop
strategi
includ
metal
nanoparticl
dissolut
nanocryst
ion
exchang
enzym
mimic
reduct
nanoparticl
enlarg
compar
enzym
metalbas
signalamplif
distinct
advantag
longterm
storag
thermal
stabil
howev
mani
strategi
suffer
follow
drawback
amplif
often
requir
addit
step
integr
pointofcar
test
workflow
incorpor
paperbas
format
technic
challeng
howev
innov
assay
design
overcom
challeng
integr
signal
amplif
pointofcar
test
drastic
improv
analyt
diagnost
sensit
result
earlier
diagnos
detect
lowdens
infect
therefor
diagnost
incorpor
novel
userfriendli
signal
amplif
step
could
fill
need
elimin
campaign
surveil
program
section
review
metalbas
signal
amplif
strategi
show
promis
applic
lowresourc
infecti
diseas
diagnost
nanoparticl
dissolut
cation
exchang
heart
signal
amplif
principl
biomark
target
captur
assay
mani
signalgener
element
particl
molecul
atom
electron
photon
etc
produc
typic
nanoparticlebas
assay
singl
nanoparticl
often
indic
presenc
one
biomolecul
howev
singl
nanoparticl
dens
pack
lattic
thousand
million
metal
atom
nanoparticl
dissolut
cation
exchang
leverag
signal
gener
figur
metal
ion
chelat
reagent
result
chromogen
fluoresc
signal
long
use
detect
trace
metal
myriad
applic
recent
tong
et
al
exploit
ferrou
ionchel
ferrozin
iron
oxid
nanoparticlelink
immunosorb
assay
ilisa
antibodyfunction
wustit
feo
particl
use
detect
element
direct
competit
indirect
sandwich
wellplat
assay
function
ironoxid
particl
bound
target
nanocryst
treat
acid
reduc
agent
result
stoichiometr
convers
ferrou
ion
thu
thousand
fe
ion
releas
biomark
present
excess
ferrozin
ad
solut
chang
transpar
purpl
upon
chelat
intens
directli
proport
iron
concentr
solut
proofofconcept
assay
detect
mous
igg
low
picomolar
detect
limit
similar
assay
depend
enzymat
signal
amplif
extend
applic
amplif
technolog
group
also
demonstr
use
western
blot
switch
chelat
reagent
potassium
ferrocyanid
prussian
blue
reagent
could
easili
precipit
onto
cellulos
membran
iron
oxid
particl
use
detect
element
wellplat
assay
far
applic
field
set
ilisa
system
could
translat
aptli
design
paper
diagnost
format
anoth
avenu
signal
amplif
similar
nanoparticl
dissolut
nanocryst
cation
exchang
cation
within
nanocryst
placeexchang
differ
cation
bulk
solidphas
cation
exchang
often
requir
elev
temperatur
sever
week
complet
nanoscal
exchang
occur
within
second
due
increas
surfac
area
lower
energi
barrier
diffus
ion
cation
exchang
employ
bioassay
nanocryst
znse
zn
cdse
cu
first
function
targetspecif
molecular
recognit
element
antibodi
aptam
util
detect
probe
use
rapid
silver
ion
exchang
bound
nanocryst
releas
thousand
zn
cd
cu
ion
zinc
cadmium
ion
detect
use
fluorogen
chelat
reagent
respect
cu
detect
chemiluminesc
reaction
luminol
h
reaction
produc
amplifi
stoichiometr
signal
employ
wellplat
magnet
beadbas
immunoassay
protein
cell
detect
well
roll
circl
amplif
dna
mirna
detect
despit
versatil
cation
exchang
method
yet
appli
paperbas
format
similar
ilisa
exampl
discuss
previous
signal
amplif
use
nanocryst
cation
exchang
would
requir
precipit
reagent
metal
ion
detect
well
clever
design
paper
microfluid
devic
enzymat
signal
amplif
result
high
analyt
sensit
easili
perform
control
laboratori
environ
howev
discuss
section
elev
temperatur
often
lead
decreas
catalyt
turnov
make
difficult
incorpor
enzymat
signal
amplif
lowresourc
infecti
diseas
diagnost
recent
year
inorgan
nanoparticl
includ
nobl
metal
rare
earth
magnet
nanoparticl
found
display
surpris
enzymelik
catalyt
activ
nanomaterialbas
artifici
enzym
origin
dub
nanozym
manea
et
al
highli
stabl
toward
rang
temperatur
ph
degrad
proteas
catalyt
activ
inorgan
nanoparticl
tune
particl
size
shape
coat
modif
composit
reason
nanozym
incorpor
myriad
sensor
variou
applic
gao
et
al
made
surpris
discoveri
magnetit
fe
nanoparticl
intrins
peroxidaselik
activ
display
kinet
consist
pingpong
mechan
fe
magnet
nanoparticl
found
catalyt
turn
sever
common
horseradish
peroxidas
substrat
includ
tmb
dab
ophenylenediamin
opd
catalyt
turnov
number
equal
improv
horseradish
peroxidas
group
demonstr
particl
could
use
place
horseradish
peroxidas
tradit
immunoassay
magnet
properti
fe
could
leverag
enrich
biomark
detect
result
semin
work
magnet
nanoparticl
employ
signal
amplif
element
protein
dna
bioassay
varieti
infecti
diseas
includ
ebola
rotaviru
mycoplasma
pneumonia
vibrio
cholera
chlamydia
trachomati
l
monocytogen
enterobact
sakazakii
salmonella
typhimurium
beyond
magnetit
sever
type
nanoparticl
includ
gold
platinum
hybrid
particl
mof
util
enzym
mimic
bioassay
target
respiratori
syncyti
viru
avian
influenza
salmonella
e
coli
hepat
c
hiv
staphylococcu
aureu
mani
assay
util
review
nanozym
catalyt
turnov
reagent
detect
format
similarli
immunoassay
surfac
well
plate
sever
group
translat
technolog
later
flow
format
found
nanozym
detect
element
result
least
improv
limit
detect
compar
tradit
gold
nanoparticlebas
later
flow
strip
exampl
loynachan
et
al
develop
ultrasensit
later
flow
assay
detect
hiv
antigen
use
porou
platinum
au
pt
nanozym
catalyz
precipit
cndab
tetrahydrochlorid
presenc
h
figur
incorpor
detect
scheme
well
care
systemat
design
affin
reagent
captur
detect
result
later
flow
assay
femtomolar
detect
limit
sensit
laboratorybas
elisa
method
nearli
order
magnitud
sensit
commerci
avail
rapid
test
visual
signal
vari
linearli
concentr
catalyt
signal
amplif
test
also
ultrabroad
dynam
rang
advantag
nanoparticl
enzym
mimic
directli
demonstr
stabil
test
activ
lyophil
porou
pt
nanocatalyst
conjug
lyophil
hrp
conjug
measur
time
enzym
conjug
lost
nearli
activ
day
storag
room
temperatur
nanocatalyst
maintain
initi
activ
store
room
temperatur
nearli
initi
activ
store
day
howev
note
optim
hrp
lyophil
storag
condit
discuss
section
employ
studi
achiev
signific
improv
sensit
use
nanozym
wash
step
substrat
addit
step
reaction
quench
step
insert
later
flow
assay
workflow
initi
signal
develop
addit
step
make
assay
similar
diagnost
difficult
perform
field
redesign
paper
devic
autom
later
flow
cassett
could
simplifi
workflow
review
allow
applic
nanozym
field
set
provid
muchneed
signal
amplif
improv
sensit
lowresourc
infecti
diseas
diagnost
reduct
nanoparticl
enlarg
use
gold
nanoparticl
detect
element
commerci
avail
later
flow
assay
ubiquit
particl
use
assay
typic
nm
detect
either
visual
without
optic
equip
use
simpl
handheld
reader
often
detect
limit
assay
low
enough
diagnos
lowdens
infect
one
simpl
solut
improv
sensit
chemic
enlarg
particl
make
visual
intens
process
later
flow
assay
run
typic
manner
antigen
present
gold
nanoparticlecontain
sandwich
complex
form
test
line
next
enhanc
solut
consist
molecular
precursor
reduc
agent
ad
test
gold
nanoparticl
test
control
line
serv
nucleat
site
solid
metal
deposit
common
format
particl
enlarg
silver
enhanc
base
photograph
techniqu
involv
reduct
silver
ion
eg
silver
nitrat
silver
metal
surfac
gold
particl
acid
buffer
solut
contain
hydroquinon
process
similar
seededgrowth
nanoparticl
synthesi
method
result
particl
hundr
nanomet
sever
micromet
diamet
figur
silver
enhanc
found
first
biolog
applic
tissu
stain
mani
commerci
avail
silver
enhanc
solut
design
microscopi
applic
sigma
thermo
ted
pella
nano
etc
first
applic
silver
enhanc
paper
diagnost
horton
et
al
develop
proofofconcept
later
flow
assay
detect
mous
igg
demonstr
silver
treatment
result
improv
detect
limit
sinc
silver
enhanc
success
improv
detect
mani
infecti
diseas
sever
order
magnitud
includ
influenza
hiv
malaria
pesti
e
coli
one
drawback
silver
enhanc
later
flow
assay
must
perform
test
complet
initi
develop
increas
total
number
step
requir
reduc
likelihood
test
could
appli
field
exampl
one
group
found
silver
enhanc
improv
detect
limit
pesti
test
order
take
advantag
impress
enhanc
author
allow
gold
test
develop
usual
wash
strip
three
time
submerg
enhanc
reagent
min
stop
reaction
sodium
thiosulf
procedur
feasibl
district
hospit
even
local
health
outpost
minim
resourc
enhanc
assay
would
true
asset
set
plagu
pandem
occur
howev
addit
step
requir
signal
amplif
make
poc
applic
lowresourc
field
set
unlik
reason
group
employ
silver
enhanc
step
paper
diagnost
assay
move
away
tradit
later
flow
assay
format
toward
altern
format
allow
autom
deliveri
silver
enhanc
reagent
test
line
fujifilm
appli
expertis
photo
technolog
develop
benchtop
workstat
autom
silver
enhanc
influenza
rapid
diagnost
test
format
user
ad
sampl
later
flow
cartridg
contain
reagent
necessari
test
wash
silver
enhanc
cartridg
insert
benchtop
workstat
releas
solut
time
autom
manner
provid
quantit
readout
strip
test
develop
complet
despit
fact
instrument
greatli
simplifi
assay
protocol
user
requir
reliabl
sourc
electr
greatli
inhibit
applic
field
set
recent
yager
fu
group
design
reli
uniqu
paper
geometri
embed
paperfluid
valv
enabl
program
electricityfre
deliveri
silver
enhanc
reagent
assay
test
line
simpli
requir
addit
sampl
buffer
pad
preload
assay
reagent
mirror
number
step
requir
run
tradit
later
flow
assay
uniqu
physic
structur
allow
precis
time
deliveri
sampl
gold
conjug
final
silver
enhanc
reagent
test
line
similarli
cho
et
al
develop
crossflow
chromatographi
system
silver
enhanc
reagent
embed
paper
rehydr
later
flow
assay
develop
enhanc
reagent
flow
perpendicular
initi
immunochromatograph
test
test
control
line
creativ
approach
redesign
later
flow
assay
make
silver
enhanc
fielddeploy
metalbas
signal
amplif
strategi
date
although
largescal
manufactur
requir
must
consid
determin
scalabl
test
design
final
note
silver
enhanc
gold
particl
common
metal
use
reduct
nanoparticl
enlarg
later
flow
enhanc
gold
deposit
onto
gold
silver
nanoparticl
silver
onto
silver
platinum
nanoparticl
mani
exampl
solut
microfluid
assay
employ
reduct
nanoparticl
enlarg
visual
electrochem
signal
amplif
format
less
conduc
lowresourc
diseas
diagnosi
biobarcod
amplif
method
discuss
thu
far
increas
number
signal
element
initi
assay
develop
requir
addit
step
post
hoc
anoth
amplif
strategi
gener
greater
number
detect
molecul
midassay
therebi
increas
downstream
signal
output
assay
mirkin
group
demonstr
protein
biomark
target
could
detect
indirectli
highli
sensit
manner
employ
gold
nanoparticl
function
dna
tag
strategi
magnet
microparticl
function
targetspecif
antibodi
ad
biolog
sampl
biomark
captur
supernat
remov
intermedi
detect
element
ad
particl
detect
element
consist
gold
nanoparticl
function
low
densiti
targetspecif
antibodi
high
densiti
doublestrand
barcod
dna
use
extern
magnet
gold
nanoparticl
bound
target
separ
barcod
dna
dehybrid
detect
downstream
figur
number
barcod
tag
much
higher
number
captur
biomark
result
signal
amplifi
compar
direct
detect
method
one
power
advantag
modular
assay
format
could
easili
multiplex
distinct
barcod
tag
target
interest
biobarcod
method
initi
appli
detect
protein
also
appli
nucleic
acid
detect
simpli
replac
biomarkerspecif
antibodi
dna
complementari
nucleic
acid
target
allow
detect
dna
rna
target
pcrlike
sensit
sinc
develop
biobarcod
assay
format
util
detect
infecti
diseas
hepat
b
hepat
c
variola
viru
ebola
hiv
b
anthraci
salmonella
well
creactiv
protein
varieti
cytokin
despit
promis
sensit
detect
biobarcod
assay
format
suffer
two
major
drawback
high
number
user
step
requir
barcod
tag
releas
detect
make
extrem
difficult
adapt
lowresourc
format
lowresourc
detect
nucleic
acid
tag
remain
challeng
initi
detect
strategi
biobarcod
assay
scanometr
barcod
tag
detect
sandwich
hybrid
assay
surfac
glass
slide
gold
nanoparticl
detect
element
signal
enhanc
use
reduct
silver
deposit
slide
evalu
use
imag
analysi
method
pcr
mass
spectrometri
electr
detect
employ
detect
barcod
tag
well
nam
et
al
develop
colorimetr
assay
releas
gold
nanoparticl
biobarcod
tag
introduc
second
solut
gold
nanoparticl
function
singlestrand
dna
complementari
tag
hybrid
biobarcod
tag
complementari
dna
result
aggreg
two
gold
nanoparticledna
conjug
yield
detect
color
chang
none
detect
method
employ
field
set
howev
difficult
imagin
develop
hybridizationbas
later
flow
assay
barcod
tag
detect
function
tag
moieti
biotin
flag
peptid
could
make
readili
detect
paper
diagnost
format
evidenc
section
signific
advanc
made
develop
metalloenzymeand
metal
nanoparticlebas
signal
amplif
strategi
infecti
diseas
diagnosi
howev
even
advanc
metalloenzym
stabil
highli
stabl
nanoparticlebas
approach
poc
assay
util
signal
amplif
still
scarc
assay
discuss
even
employ
paper
substrat
later
flow
format
requir
mani
user
step
signal
gener
futur
work
minim
user
step
instanc
use
vertic
flow
assay
format
critic
translat
signal
amplif
strategi
laboratori
test
assay
run
primari
healthcar
facil
moreov
assay
discuss
section
also
heavili
reliant
benchtop
laboratorybas
instrument
signal
readout
next
section
discuss
variou
type
fielddeploy
instrument
develop
effort
bring
quantit
sensit
assay
discuss
section
lowresourc
set
tradit
pointofcar
diagnost
later
flow
assay
deliv
qualit
visual
result
although
simplic
advantag
field
diagnost
sensit
specif
suffer
subject
interpret
user
bia
error
quantit
measur
mitig
factor
avoid
data
loss
associ
qualit
test
provid
insight
import
variabl
infect
intens
biomark
express
pattern
elimin
set
paramet
allow
robust
epidemiolog
studi
transmiss
dynam
intervent
efficaci
novel
detect
strategi
offer
highli
sensit
quantit
result
includ
mani
outlin
section
requir
instrument
signal
readout
result
develop
appropri
simpl
instrument
like
becom
integr
part
applic
diagnost
technolog
lowresourc
set
incorpor
detect
devic
pointofcar
diagnost
effect
elimin
possibl
equipmentfre
test
e
assur
criteria
reduc
afford
natur
simpl
test
assur
criteria
howev
potenti
benefit
instrument
includ
improv
sensit
reduc
bia
outweigh
disadvantag
mani
usecas
scenario
overal
cost
instrument
per
test
reduc
devic
use
evalu
mani
test
time
addit
mani
instrument
incorpor
common
consum
electron
devic
mobil
phone
smart
phone
therebi
reduc
equip
burden
section
outlin
devic
develop
pointofcar
infecti
diseas
diagnosi
tabl
includ
begin
section
highlight
select
exampl
pointofcar
instrument
vast
major
metalbas
probe
nanoparticl
highlight
section
produc
optic
signal
absorb
fluoresc
phosphoresc
result
divers
array
instrument
develop
facilit
assay
readout
imag
quantit
purpos
section
provid
overview
effort
develop
portabl
afford
sensit
instrument
optic
detect
lowresourc
set
microscopi
convent
microscopi
remain
gold
standard
diagnost
techniqu
mani
infecti
diseas
includ
malaria
tuberculosi
schistosomiasi
intestin
protozoa
detect
diseas
varieti
microscop
techniqu
bright
field
dark
field
fluoresc
microscopi
use
direct
inspect
stain
unstain
smear
blood
sputum
urin
etc
microscopi
use
diagnost
tool
result
depend
strongli
infect
intens
sampl
prepar
method
train
level
microscopist
challeng
lead
variabl
reduc
util
microscopybas
diagnosi
field
set
especi
lowtransmiss
area
addit
microscop
instrument
expens
bulki
address
drawback
mani
group
develop
portabl
afford
easytous
microscopi
tool
suitabl
lowresourc
set
one
approach
bring
laboratorybas
microscopi
tool
lowresourc
set
involv
build
simpl
portabl
andor
miniatur
microscop
lowcost
materi
solut
address
primari
disadvantag
microscopi
poc
diagnost
ie
need
skill
microscopist
sampl
prepar
requir
allow
convent
microscop
platform
deploy
difficult
set
low
cost
devic
typic
replac
highenergi
expens
light
sourc
led
reduc
expens
power
requir
illumin
addit
increas
light
sourc
lifetim
structur
compon
microscop
often
threedimension
print
afford
plastic
hybrid
lens
fiber
optic
replac
expens
delic
glass
lens
tuberculosi
sampl
evalu
posit
neg
tuberculosi
result
global
focu
microscop
laboratorygrad
fluoresc
microscop
agreement
case
mani
similarli
portabl
lightweight
microscop
develop
includ
tomograph
holograph
widefield
fluoresc
microscop
impress
weigh
less
g
microscop
appli
detect
tuberculosi
also
malaria
soiltransmit
helminth
schistosomiasi
hymenolepi
nana
foldscop
exampl
lowresourc
microscop
embodi
assur
criteria
assembl
use
principl
origami
foldscop
construct
flat
paper
copper
tape
buttoncel
batteri
led
polym
filter
ball
len
figur
entir
devic
cost
less
achiev
magnif
shown
capabl
detect
giardia
lamblia
leishmania
donovani
trypanosoma
cruzi
e
coli
schistosoma
hematobium
egg
despit
accomplish
foldscop
appli
hematobium
detect
field
set
diagnost
sensit
compar
convent
light
microscopi
limit
sensit
like
result
challeng
physic
manipul
foldscop
integr
smartphon
display
word
foldscop
fail
satisfi
u
userfriendli
assur
criteria
particular
usecas
exampl
demonstr
import
rigor
field
evalu
novel
diagnost
devic
indic
improv
foldscop
must
made
implement
case
manag
recent
mobil
phonebas
microscopi
emerg
potenti
altern
convent
microscop
infecti
diseas
diagnost
phonebas
brightfield
fluoresc
darkfield
microscopi
devic
develop
often
employ
compact
pockets
attach
figur
devic
appli
detect
myriad
infecti
diseas
includ
malaria
tuberculosi
schistosomiasi
human
papillomaviru
hpv
soiltransmit
helminth
filari
diseas
intestin
protozoa
repurpos
mobil
phone
advantag
due
widespread
adopt
grow
connect
lowresourc
set
addit
acquisit
digit
imag
could
allow
imageprocess
local
remot
autom
diagnos
near
realtim
data
transmiss
advantag
coupl
diseasespecif
softwar
applic
could
potenti
decreas
user
variabl
typic
associ
microscopi
improv
case
manag
epidemiolog
studi
one
exampl
leverag
advantag
loascop
develop
fletcher
group
figur
loascop
smartphonebas
devic
combin
video
microscopi
autom
softwar
onboard
quantit
detect
base
movement
filari
parasit
loa
loa
whole
blood
applic
download
smartphon
use
stage
control
video
captur
imag
analysi
data
report
quantit
l
loa
microfilaria
densiti
detect
l
loa
import
high
level
microfilaria
associ
potenti
fatal
advers
event
treatment
ivermectin
drug
frequent
use
mass
drug
administr
effort
onchocerciasi
lymphat
filariasi
lf
advers
event
led
suspens
mass
drug
administr
campaign
subsequ
major
setback
onchocerciasi
lf
elimin
effort
rapid
pointofcar
measur
l
loa
infect
intens
could
allow
elimin
campaign
resum
devic
valid
field
set
yield
result
similar
thick
smear
appli
largescal
particip
testandnottreat
approach
onchocerciasi
area
high
preval
particip
mass
drug
administr
campaign
sinc
due
preval
l
loa
patient
screen
l
loa
burden
use
loascop
high
count
given
ivermectin
treat
l
loa
albendazol
strike
exampl
mobil
phonebas
microscopi
field
loascop
measur
perform
oper
one
hour
train
applicationspecif
softwar
significantli
decreas
probabl
user
error
elimin
need
subject
interpret
result
total
loascop
enabl
ivermectin
deliveri
particip
otherwis
would
receiv
treatment
onchocerciasi
demonstr
incred
impact
mobil
phone
microscopi
appli
detect
infecti
diseas
despit
fact
mani
mobil
phonebas
microscop
lack
analyt
diagnost
sensit
convent
microscop
loascop
excel
demonstr
mobil
phone
microscopi
highli
impact
appli
appropri
usecas
scenario
particular
studi
focus
identifi
patient
high
l
loa
burden
unclear
extent
devic
could
detect
lowburden
infect
gener
technolog
filari
diseas
also
requir
studi
addit
potenti
interfer
filari
parasit
need
studi
work
continu
field
lowresourc
microscopi
import
develop
new
tool
specif
usecas
scenario
mind
one
potenti
avenu
applicationbas
innov
involv
develop
lowresourc
sampl
prepar
method
coupl
novel
probe
inorgan
complex
nanoparticl
discuss
section
later
flow
analysi
much
progress
made
develop
rug
fieldapplic
microscopi
devic
later
flow
assay
current
remain
fieldfriendli
format
infecti
diseas
diagnosi
howev
simpl
direct
visual
readout
later
flow
assay
often
cite
one
primari
advantag
format
also
consid
achil
heel
difficulti
interpret
result
visual
impair
oper
bia
result
usertous
variat
test
interpret
maintain
accur
record
commun
test
result
local
nation
health
organ
remain
substanti
challeng
overcom
challeng
number
optic
reader
develop
commerci
provid
rapid
object
quantit
measur
signal
later
flow
assay
underli
instrument
within
reader
gener
group
two
categori
optomechan
scan
imag
scan
reader
primari
optic
compon
includ
light
sourc
led
laser
photodiod
specif
compon
tailor
specif
detect
element
use
particular
assay
light
sourc
power
wavelength
determin
absorb
excit
wavelength
label
employ
specif
test
light
sourc
raster
along
later
flow
strip
photodiod
detect
reflect
emiss
depend
whether
colorimetr
fluoresc
label
use
measur
typic
record
millivolt
mv
unit
though
biomark
concentr
obtain
calibr
curv
establish
color
particl
present
control
test
line
absorb
incid
light
result
quantifi
decreas
reflect
fluoresc
label
intens
emit
light
increas
light
sourc
pass
control
test
line
optic
configur
either
specular
confoc
arrang
specular
arrang
primarili
use
colorimetr
label
photodiod
posit
collect
light
reflect
test
angl
incid
light
sourc
confoc
scan
system
use
measur
reflect
fluoresc
case
incid
light
focus
point
later
flow
strip
photodiod
place
focal
point
light
return
strip
whether
reflect
emit
pass
apertur
exclud
ray
directli
focal
point
elimin
background
scatter
case
fluoresc
label
dichroic
mirror
filter
often
place
apertur
specular
confoc
scan
configur
sensit
z
posit
later
flow
strip
specular
arrang
small
deviat
along
z
axi
result
reflect
light
complet
miss
photodiod
due
misalign
confoc
system
slightli
toler
small
variat
along
z
axi
depend
size
pinhol
apertur
howev
even
slight
variat
focal
plane
drastic
decreas
number
photon
reach
photodiod
alter
quantit
output
anoth
challeng
associ
confoc
specular
optomechan
scan
strip
reader
point
incid
light
cover
test
control
line
especi
problemat
concentr
particl
vari
along
test
control
line
due
improp
flow
manufactur
variat
despit
challeng
scan
system
advantag
due
low
cost
rel
simplic
one
wide
use
commerci
system
esequ
line
later
flow
reader
manufactur
qiagen
inc
figur
qiagen
offer
custom
optic
colorimetr
fluoresc
chemiluminesc
upconvert
phosphor
label
user
take
account
system
often
vari
sensit
gener
rule
smaller
portabl
system
rare
perform
well
benchtop
counterpart
exampl
van
dam
et
al
found
portabl
commerci
reader
ucpquant
qiagen
least
order
magnitud
less
sensit
custommodifi
benchtop
reader
evalu
upconvert
phosphorbas
schistosomiasi
later
flow
assay
consequ
select
scan
later
flow
strip
reader
particular
applic
requir
consider
portabl
sensit
imagingbas
later
flow
reader
greatli
reduc
optic
equip
requir
quantifi
later
flow
assay
system
produc
pictur
record
later
flow
assay
use
charg
coupl
devic
ccd
complementari
metaloxidesemiconductor
cmo
detector
reli
imag
process
softwar
detect
andor
quantifi
intens
test
line
benefit
format
includ
abil
store
test
imag
alongsid
patient
record
lack
move
part
make
imagingbas
reader
robust
field
condit
imag
analysi
softwar
identifi
correct
nonuniform
signal
allow
analysi
full
test
line
imagingbas
reader
use
detect
colorimetr
fluoresc
label
latter
case
hardwar
excit
requir
filter
ad
improv
imag
qualiti
sinc
test
posit
illumin
affect
imag
analysi
mani
camerabas
later
flow
reader
includ
hous
unit
runtorun
consist
commerci
later
flow
imag
devic
includ
deki
reader
fio
axxin
inc
skansmart
skannex
pro
detekt
biomed
llc
figur
devic
use
quantif
malaria
dengu
burkholderia
pseudomallei
pesti
later
flow
assay
deki
reader
test
extens
field
imagebas
later
flow
quantif
translat
well
mobil
phone
technolog
especi
smartphon
camera
qualiti
improv
mobil
phone
use
quantifi
later
flow
assay
numer
diseas
includ
malaria
hiv
tuberculosi
similar
commerci
avail
imagingbas
reader
mani
studi
requir
extern
devic
ensur
consist
illumin
distanc
camera
order
maintain
consist
imag
analysi
recent
scherr
et
al
develop
later
flow
imag
platform
use
unmodifi
mobil
phone
hardwar
reli
softwar
imag
analysi
later
flow
imag
captur
ambient
light
condit
imag
sent
secur
web
databas
redcap
analyz
use
matlabbas
algorithm
quantit
result
sent
back
redcap
deliv
phone
real
time
softwarebas
imag
platform
toler
moder
variat
test
orient
distanc
illumin
make
data
collect
easi
take
cell
phone
pictur
compar
scan
esequ
later
flow
reader
process
platform
found
improv
detect
limit
addit
algorithm
reliabl
work
camera
resolut
megapixel
suggest
modern
mobil
phone
camera
could
captur
imag
suffici
qualiti
imag
process
softwar
work
mobil
phone
incorpor
lowresourc
diagnost
workflow
import
ask
whether
convent
later
flow
format
redesign
take
full
advantag
potenti
benefit
smartphon
offer
word
chang
made
diagnost
test
format
maintain
simplic
later
flow
assay
enabl
improv
quantif
commun
aggreg
test
result
one
option
emb
quick
respons
qr
code
later
flow
test
idea
approach
number
way
includ
place
sticker
later
flow
test
ad
transpar
overlay
test
control
line
becom
part
qr
code
format
embed
barcod
either
static
provid
use
inform
brand
lot
patient
id
dynam
produc
positiveneg
readout
scherr
et
al
develop
novel
platform
control
line
later
flow
assay
replac
control
grid
pattern
shape
qr
code
figur
qr
code
function
flow
control
appear
posit
neg
test
invalid
test
qr
code
also
trigger
data
analysi
enabl
correct
light
effect
scan
manufactur
detail
quickli
easili
access
time
test
line
quantifi
difficult
imagin
impact
test
format
could
combin
data
commun
aggreg
abil
smartphon
epidemiolog
surveil
studi
could
account
variabl
even
current
consid
studi
manufactur
batchtobatch
variat
geograph
data
could
also
coupl
specif
rapid
test
tool
autom
read
later
flow
assay
becom
preval
establish
standard
consist
report
data
manag
import
like
later
flow
assay
testread
instrument
need
valid
ensur
proper
consist
biomark
quantif
across
differ
devic
test
brand
although
optic
later
flow
reader
may
detect
test
line
invis
human
eye
reader
alon
replac
need
ultrasensit
later
flow
test
smartphoneen
optic
measur
mobil
phone
adapt
optic
measur
beyond
later
flow
quantif
one
exampl
mobil
phonebas
handheld
micropl
reader
develop
berg
et
al
devic
consist
attach
led
array
illumin
well
transmit
light
collect
via
individu
optic
fiber
result
visual
deliv
user
one
minut
within
custom
mobil
phone
app
devic
shown
accur
immunoassay
detect
mump
igg
measl
igg
herp
simplex
viru
igg
compar
fdaapprov
clinic
spectrophotomet
microplatebas
immunoassay
feasibl
field
set
devic
could
make
true
impact
resourcelimit
clinic
excel
altern
tradit
bulki
expens
spectrophotomet
addit
devic
attach
mobil
phone
offer
potenti
rapidli
commun
aggreg
result
enabl
largescal
epidemiolog
studi
mobil
phone
attach
optic
detect
modal
develop
well
one
excit
exampl
long
et
al
develop
trianalyz
trimod
smartphon
attach
capabl
measur
transmiss
reflect
emiss
intens
multifunct
devic
leverag
white
light
smartphon
rearfac
flash
led
integr
green
laser
diod
sampl
illumin
via
optic
fiber
optic
fiber
collect
light
transmit
emit
sampl
light
reflect
photon
crystal
biosensor
collect
light
collim
focus
dispers
diffract
grate
onto
smartphon
cmo
sensor
intens
wavelength
determin
integr
pixel
intens
correspond
posit
along
sensor
clever
detect
strategi
allow
full
absorb
emiss
spectra
collect
simpl
smartphonebas
devic
two
proofofconcept
assay
develop
devic
could
detect
analyt
lower
concentr
detect
use
convent
laboratori
instrument
indic
miniatur
technolog
result
tradeoff
sensit
thu
trimod
smartphon
attach
enabl
quantit
laboratoryqu
optic
measur
one
fingertip
similarli
format
mobil
phonebas
spectrophotomet
surfac
plasmon
reson
sensor
flow
cytomet
also
develop
miniatur
decreas
cost
associ
smartphoneen
tool
make
chemic
review
laboratori
techniqu
possibl
would
otherwis
inaccess
lowresourc
set
nobl
metal
nanoparticl
extrem
high
molar
absorpt
make
ideal
visual
label
later
flow
assay
intens
absorb
occur
particl
excit
light
match
reson
oscil
free
electron
electron
relax
ground
state
releas
energi
form
heat
surround
amount
heat
gener
equal
product
number
nobl
metal
nanoparticl
crosssect
area
nanoparticl
intens
incid
light
recent
bischof
group
took
advantag
uniqu
thermophys
properti
develop
novel
method
later
flow
quantif
base
thermal
contrast
gold
nanoparticl
method
highpow
green
laser
use
excit
gold
nanoparticl
infrareddetect
camera
employ
measur
result
thermal
contrast
earli
benchtop
prototyp
devic
demonstr
improv
detect
limit
fda
approv
later
flow
assay
cryptococc
capsular
polysaccharid
glucuronoxylomannan
antigen
crag
crag
biomark
cryptococc
infect
opportunist
fungal
infect
among
lead
caus
death
patient
aid
common
caus
adult
mening
subsaharan
africa
thermal
contrastcoupl
crag
later
flow
assay
valid
second
studi
display
accuraci
quantifi
crag
level
patient
sampl
success
valid
prototyp
devic
group
develop
reader
incorpor
green
laser
infrar
camera
autom
control
system
benchtop
box
devic
figur
studi
demonstr
util
versatil
thermal
contrast
method
quantif
later
flow
assay
varieti
vendor
multipl
diseas
improv
detect
threshold
compar
visual
inspect
found
later
flow
assay
influenza
bd
veritor
malaria
first
respons
sd
biolin
parahit
clostridium
difficil
ridaquick
separ
studi
group
found
enhanc
factor
greater
nanoparticl
size
increas
suggest
redesign
later
flow
assay
could
improv
test
sensit
use
thermal
contrast
reader
thermal
contrast
repres
uniqu
versatil
method
later
flow
quantif
sever
issu
must
address
largescal
implement
includ
cost
portabl
background
signal
reduct
biolog
interfer
blood
addit
nitrocellulos
membran
highli
flammabl
appear
full
strip
ignit
occur
current
publish
studi
visibl
burn
mark
along
nitrocellulos
membran
suggest
safeti
studi
determin
limit
thermal
contrast
system
undertaken
widespread
implement
nevertheless
thermal
contrast
repres
highli
sensit
promis
tool
later
flow
quantif
surfaceenhanc
raman
spectroscopi
ser
highli
sensit
vibrat
spectroscopi
techniqu
structurebas
analyt
detect
techniqu
excit
local
surfac
plasmon
typic
nobl
metal
eg
gold
silver
substrat
nanoscal
featur
gener
amplifi
electromagnet
field
enhanc
inelast
raman
scatter
signal
analyt
interest
time
instrument
ser
detect
requir
highpow
laser
excit
sourc
typic
tune
accord
reson
frequenc
plasmon
substrat
excit
filter
use
exclud
elast
rayleigh
scatter
allow
ramanscatt
light
reach
detector
high
sensit
ser
make
attract
detect
platform
infecti
diseas
diagnost
particularli
detect
lowdens
infect
mani
laboratorybas
bioassay
protein
nucleic
acid
wholecel
biomark
leverag
ser
detect
develop
myriad
infecti
diseas
assay
gener
either
perform
surfac
particl
solut
bulk
solid
substrat
detect
element
typic
consist
nanoparticl
function
raman
report
molecul
targetspecif
molecular
recognit
element
complex
form
nanoparticl
provid
plasmon
surfac
raman
signal
enhanc
report
molecul
nanoparticl
typic
gold
silver
au
ag
particl
come
varieti
shape
provid
optim
signal
enhanc
smallmolecul
raman
report
acid
malachit
green
often
employ
biomolecul
target
typic
complex
vibrat
signatur
frequent
far
away
plasmon
surfac
sensit
detect
identif
bulki
natur
resourc
requir
ser
detect
remain
primari
barrier
implement
pointofcar
set
sever
handheld
raman
spectromet
develop
commerci
includ
firstdefend
thermofish
scientif
inc
nanoram
b
w
tek
progeni
rigaku
corp
devic
advertis
identif
unknown
substanc
forens
environment
militari
firstrespons
context
qualiti
control
industri
set
mani
studi
util
sersbas
detect
infecti
diseas
biomark
suggest
commerci
avail
portabl
devic
could
util
analysi
sersbas
later
flow
assay
none
studi
actual
implement
handheld
devic
accordingli
unknown
whether
devic
suffici
sensit
spatial
resolut
use
effect
lowresourc
diagnost
paramet
along
cost
analysi
studi
determin
whether
current
commerci
devic
could
implement
magnet
nanoparticl
possess
advantag
optic
later
flow
label
signal
rare
hinder
test
opac
biolog
interfer
detail
discuss
qualiti
well
exampl
specif
assay
employ
magnet
nanoparticl
provid
section
discuss
instrument
requir
magnet
particl
detect
varieti
method
detect
paramagnet
superparamagnet
nanoparticl
later
flow
assay
base
either
induct
effect
magnetoresist
exampl
magnabiosci
usa
develop
inductionbas
devic
use
extens
literatur
detect
infecti
diseas
anthrax
solium
hiv
v
parahemolyticu
l
monocytogen
format
later
flow
assay
place
insid
oscil
magnet
field
set
induct
coil
instrument
measur
induc
electromot
forc
v
coil
assay
quantifi
technolog
gener
greater
sensit
compar
visual
detect
iron
oxid
particl
current
iter
magnabiosci
reader
rel
larg
benchtop
devic
unsuit
use
lowresourc
set
portabl
version
develop
compani
magnasens
finland
magnisens
franc
develop
portabl
handheld
devic
base
induct
detect
paramagnet
particl
though
devic
extens
test
literatur
sever
group
develop
later
flow
assay
reader
use
magnetoresist
sensor
devic
base
principl
electr
resist
certain
materi
incorpor
sensor
chang
upon
applic
extern
magnet
field
sever
type
sensor
base
magnetoresist
common
giant
magnetoresist
gmr
sensor
use
read
head
hard
disk
drive
appli
later
flow
assay
gmr
sensor
place
close
proxim
test
control
line
extern
magnet
field
appli
test
extern
field
align
magnet
moment
paramagnet
superparamagnet
later
flow
detect
report
align
produc
fring
field
detect
chang
resist
constant
current
appli
across
gmr
sensor
magnetoresist
sensor
appli
extens
research
detect
magnet
particl
label
later
flow
assay
howev
proofofprincipl
studi
use
imit
later
flow
assay
test
biomark
hcg
cardiac
troponin
high
sensit
magnet
detect
later
flow
assay
make
techniqu
attract
infecti
diseas
diagnosi
magnet
detect
necessit
instrument
result
readout
ironcontain
magnet
nanoparticl
also
ad
advantag
highli
absorb
visual
label
thu
magnet
nanoparticl
potenti
appli
differ
usecas
scenario
differ
sensit
requir
usecas
scenario
morbid
control
import
identifi
highintens
infect
field
visual
detect
magnet
particl
would
suffici
improv
sensit
desir
detect
lowintens
infect
epidemiolog
surveil
purpos
analysi
use
current
instrument
read
magnet
nanoparticl
label
could
perform
district
hospit
laboratori
howev
work
miniatur
instrument
valid
handheld
reader
requir
field
applic
magnet
detect
later
flow
assay
discuss
previou
section
electrochem
detect
offer
sever
benefit
poc
infecti
diseas
detect
name
inexpens
sensit
rapid
quantit
electrochem
detect
system
previous
discuss
larg
proofofconcept
diagnost
detect
protein
nucleic
acid
biomark
infrastructur
requir
carri
assay
would
limit
util
primari
healthcar
set
lowand
middleincom
countri
integr
valid
fieldreadi
electrochem
detect
system
develop
electrochem
assay
repres
viabl
strategi
implement
next
gener
poc
diagnost
blood
glucos
biosensor
remark
success
electrochem
devic
ubiquit
appli
point
care
gener
electrochem
glucos
meter
kit
consist
three
compon
lancet
sampl
collect
plastic
test
strip
wick
glucosecontain
sampl
gener
current
devic
digit
readout
gener
current
test
strip
hous
electrochem
cell
contain
counterrefer
electrod
filldetect
electrod
enzymeco
work
electrod
mediat
figur
devic
work
electrod
coat
enzym
glucos
oxidas
gox
glucos
dehydrogenas
gdh
enzym
oxid
glucos
present
blood
sampl
ferrocen
deriv
group
viii
metal
complex
act
mediat
facilit
electron
transfer
enzym
redox
center
electrod
surfac
therebi
produc
measur
current
sinc
develop
first
commerci
blood
glucos
biosensor
use
technolog
drastic
expand
current
market
offer
numer
blood
glucos
meter
portabl
rapid
sensit
quantit
blood
glucos
biosensor
enorm
impact
manag
type
ii
diabet
constant
monitor
rapid
time
result
critic
prevent
incid
hyperand
hypoglycemia
success
adapt
technolog
field
detect
infecti
diseas
would
profound
impact
diseas
surveil
elimin
campaign
sensit
quantit
result
desir
best
inform
healthcar
profession
diseas
distribut
sever
group
repurpos
commerci
blood
glucos
meter
detect
varieti
target
xiang
lu
develop
platform
util
person
glucos
meter
signal
output
detect
protein
nucleic
acid
adenosin
small
molecul
cocain
toxic
ion
uranium
target
strategi
employ
magnet
beadconjug
aptam
specif
biomark
interest
aptam
initi
prehybrid
partial
complementari
dna
strand
link
invertas
enzym
catalyz
hydrolysi
sucros
fructos
glucos
subunit
biomarkercontain
sampl
aptam
bound
biomark
releas
invertaseconjug
complementari
dna
solut
magnet
bead
remov
solut
use
extern
magnet
addit
sucros
supernat
result
glucos
product
readili
detect
person
glucos
meter
creativ
applic
extant
platform
expand
function
also
increas
number
assay
step
potenti
limit
use
directli
point
care
address
concern
lu
group
sinc
integr
solutionbas
assay
later
flow
strip
dri
reagent
elimin
sever
user
step
simplifi
platform
could
appli
point
care
innov
approach
excel
exampl
metalbas
sampl
prepar
use
magnet
bead
combin
exist
electrochem
platform
rapid
detect
varieti
diseas
target
blood
glucos
meter
clearli
demonstr
portabl
electrochem
instrument
enabl
minim
train
user
measur
analyt
point
care
rapidli
obtain
inform
regard
health
statu
mobil
health
technolog
ie
mobil
phone
telemedicin
augment
advanc
instrument
connect
individu
user
entir
healthcar
infrastructur
mobil
health
technolog
use
track
patient
inform
facilit
commun
patient
care
provid
technolog
matur
becom
increasingli
import
model
diseas
diseas
trend
throughout
variou
popul
integr
portabl
electrochem
diagnost
mobil
health
technolog
socal
connect
diagnost
pursu
interfac
electrochem
devic
mobil
phone
nemiroski
colleagu
develop
univers
mobil
electrochem
detector
ume
combin
potentiostat
virtual
mobil
phone
use
audiobas
data
transmiss
figur
devic
could
accommod
sever
electrochem
techniqu
amperometri
coulometri
voltammetri
potentiometri
voic
systembas
data
ensur
broad
compat
varieti
mobil
phone
network
author
employ
ume
detect
blood
glucos
heavi
metal
water
electrolyt
malari
biomark
follow
sampl
collect
measur
use
potentiostat
user
place
phone
call
skype
number
remot
locat
vocal
report
valu
analyt
measur
remot
applic
extract
valu
audio
data
sent
sm
messag
back
user
addit
diagnost
inform
eg
low
report
blood
glucos
level
low
although
ume
appli
detect
infecti
diseas
biomark
limit
avail
exist
compat
test
technolog
instanc
detect
requir
offlin
plate
elisa
conduct
prior
analysi
ume
transmiss
mobil
network
progress
made
electrochem
diagnost
design
ume
similar
devic
abl
reach
full
potenti
connect
diagnost
batteryoper
portabl
devic
becom
robust
electrochem
detect
devic
becom
increasingli
viabl
poc
platform
success
person
glucos
meter
testament
effect
reliabl
diagnost
perform
possibl
electrochem
measur
concurr
expans
inform
technolog
connect
electrochem
diagnost
could
serv
link
chemistri
util
point
care
remot
higher
level
healthcar
system
map
diseas
trend
inform
treatment
decis
highincom
countri
advanc
portabl
electron
instrument
enabl
live
health
track
consum
fingertip
wearabl
commerci
health
diagnost
appl
watch
garmin
fitbit
simpl
use
provid
realtim
updat
heart
rate
activ
complet
calori
burn
similar
vein
sever
emerg
healthcent
tool
presson
tattoo
skin
patch
face
mask
capabl
detect
chang
human
physiolog
point
use
addit
advent
technolog
googl
glass
allow
connect
interpret
rapid
diagnost
test
overal
wearabl
instrument
combin
sampl
collect
sampl
prepar
analysi
readout
data
transmiss
one
devic
repres
signific
progress
diagnosi
health
manag
point
care
small
electrochem
instrument
becom
focu
innov
research
field
led
number
skinbas
wearabl
diagnost
jia
et
al
detect
glucos
interstiti
fluid
skin
figur
technolog
extraordinarili
promis
futur
diagnost
devic
particularli
new
biomark
infecti
diseas
discov
surfac
biofluid
sweat
recent
advanc
microproject
microneedl
technolog
allow
research
expand
use
skinbas
wearabl
beneath
surfac
skin
sever
applic
patch
consist
mani
microproject
easili
appli
skin
gentl
press
could
draw
hundr
microlit
blood
littletono
pain
lee
et
al
outlin
design
multiplex
patch
captur
igg
malari
biomark
skin
inocul
mice
patch
consist
microproject
array
mpa
subsequ
function
antibodi
fcspecif
antimous
igg
antibodi
antidengu
antibodi
mpa
detect
biomark
antiiggfunction
mpa
act
posit
control
skin
penetr
antidenguefunction
mpa
serv
neg
control
though
sampl
collect
prepar
applic
point
use
assay
requir
elisa
colorimetr
readout
captur
antigen
research
integr
technolog
diagnost
stack
paperbas
assay
would
allow
realtim
skinbas
monitor
infecti
diseas
anoth
forthcom
applic
wearabl
instrument
breath
analysi
via
paper
mask
guder
et
al
develop
electr
sensor
monitor
respir
sensor
consist
paper
surgic
mask
print
graphit
electrod
attach
batteri
signal
amplifi
user
breath
humid
chang
inhal
exhal
gener
measur
current
across
electrod
detect
use
bluetoothconnect
mobil
devic
figur
technolog
evolv
may
possibl
adapt
analysi
breathbas
biomark
particularli
respiratori
infecti
diseas
tuberculosi
influenza
addit
incorpor
extern
batteryamplifi
pack
materi
mask
may
open
avenu
broader
distribut
particularli
lowresourc
area
likewis
person
comput
display
googl
glass
enabl
user
har
power
technolog
workstat
handsfre
glass
format
capac
could
significantli
improv
diagnost
capabl
effect
feng
et
al
develop
method
later
flow
assay
analysi
combin
visual
examin
later
flow
test
computer
imag
analysi
wireless
storag
capabl
figur
wearabl
imag
techniqu
allow
user
collect
imag
test
store
cloudbas
system
local
googl
glass
headset
internet
access
unavail
googl
glass
headset
connect
wireless
network
test
imag
could
sent
secur
server
analyz
test
result
analysi
sent
back
viewer
eyepiec
method
demonstr
use
rapid
diagnost
test
hiv
antibodi
prostat
specif
antigen
psa
though
potenti
adapt
later
flow
assay
visual
label
use
computerbas
imag
may
remov
inaccuraci
aris
subject
humanbas
interpret
result
must
also
note
number
technolog
hurdl
first
address
googl
glass
capabl
autofocus
imag
taken
good
light
white
univers
solid
simpl
backdrop
thu
technolog
limit
field
applic
addit
test
recognit
depend
preprint
qr
code
prepar
attach
test
research
use
order
effici
util
technolog
googl
glass
applic
could
adapt
identifi
test
featur
without
need
usersuppli
qr
code
webbas
test
input
would
simplifi
workflow
allow
highthroughput
analysi
diagnost
test
overal
signific
room
growth
develop
field
wearabl
instrument
wearabl
diagnost
may
previous
seem
home
world
scienc
fiction
becom
commonplac
healthrel
research
effort
develop
wearabl
diagnost
technolog
could
drastic
improv
simplic
diagnost
measur
interpret
region
littl
laboratori
infrastructur
technolog
continu
develop
applic
highresourc
area
world
scientif
commun
would
remiss
consid
impact
could
infecti
diseas
diagnosi
resourcelimit
set
inorgan
chemistri
nucleic
acid
detect
thu
far
highlight
innov
exampl
metalbas
strategi
improv
pointofcar
diagnosi
infecti
diseas
base
primarili
protein
inorgan
diseas
biomark
case
leverag
inorgan
chemistri
sampl
prepar
method
detect
probe
would
requir
minim
modif
applic
point
care
clear
despit
potenti
tradeoff
complex
workflow
instrument
increas
sensit
offer
metalbas
strategi
biomark
detect
could
significantli
improv
morbid
control
elimin
effort
mani
instanc
though
sensit
quantit
detect
presenc
absenc
diseas
paint
full
pictur
need
implement
success
control
elimin
campaign
case
pathogen
genet
materi
must
detect
extens
studi
popul
scale
order
inform
strategi
research
provid
valuabl
inform
pathogen
speci
strain
distribut
drug
resist
inform
treatment
diagnost
strategi
control
elimin
campaign
informationrich
highli
specif
natur
nucleic
acid
detect
make
biomark
attract
target
pointofcar
diagnost
fact
sever
group
begun
appli
metalbas
detect
strategi
protein
inorgan
biomark
discuss
preced
section
h
e
e
e
c
n
f
p
h
g
e
n
c
n
r
rna
instanc
mani
metalcontain
nanoparticl
probe
function
detect
pathogenspecif
nucleic
acid
sequenc
varieti
format
sizedepend
spr
noblemet
nanoparticl
leverag
aggreg
assay
multiplex
detect
middl
east
respiratori
syndrom
coronaviru
tuberculosi
hpv
format
high
conduct
agnp
exploit
electrochem
detect
tuberculosi
hiv
luminesc
particl
ie
quantum
dot
europium
chelatedop
particl
upconvert
phosphor
function
detect
myriad
diseas
includ
hiv
hbv
hcv
hpv
p
falciparum
malaria
bacillu
cereu
streptococcu
pyogen
moreov
nanoparticlebas
method
occur
varieti
format
includ
later
flow
assay
specif
nucleic
acid
sequenc
typic
present
much
lower
concentr
protein
biomark
patient
sampl
target
amplif
step
often
requir
detect
method
appli
common
target
amplif
techniqu
pcr
timeconsum
enzymebas
method
requir
technic
expertis
expens
equip
signific
laboratori
infrastructur
requir
primari
barrier
sensit
detect
pathogen
genet
materi
field
fortun
altern
target
amplif
techniqu
potenti
pointofcar
applic
emerg
exampl
biobarcod
signal
amplif
strategi
discuss
section
adapt
amplif
nucleic
acid
target
howev
gener
isotherm
enzymat
amplif
techniqu
demonstr
sensit
promis
pointofcar
diagnost
applic
isotherm
amplif
techniqu
requir
thermal
cycl
simpler
oper
requir
fewer
resourc
compar
tradit
pcr
class
enzymat
amplif
techniqu
includ
loopmedi
isotherm
amplif
lamp
helicasedepend
amplif
hda
roll
circl
amplif
rca
multipl
displac
amplif
mda
recombinas
polymeras
amplif
rpa
nucleic
acid
sequencebas
amplif
nasba
among
strategi
lamp
one
wide
valid
employ
amplif
nucleic
acid
target
varieti
diseas
infect
includ
target
malaria
hiv
hpv
bordetella
pertussi
c
trachomati
neisseri
gonorrhea
influenza
e
coli
sever
filari
parasit
addit
malaria
diagnosi
lamp
also
use
detect
artemisinin
resist
p
falciparum
malaria
techniqu
consist
iter
elong
recycl
stemloop
dna
structur
usual
requir
constant
temperatur
rel
simpl
workflow
lamp
compar
enzymat
amplif
techniqu
potenti
colorimetr
visual
readout
led
develop
sever
lowresourc
devic
nucleic
acid
detect
one
exampl
noninstru
nucleic
acid
amplif
devic
nina
reli
exotherm
chemic
reaction
mgfe
powder
salin
oxygen
coupl
phase
chang
materi
prolong
precis
heat
insid
thermo
cup
despit
streamlin
workflow
nina
devic
account
sampl
prepar
preamplif
nucleic
acid
extract
step
still
requir
laboratori
equip
heat
water
bath
centrifug
although
amplif
step
modifi
use
point
care
complet
protocol
releg
laboratori
environ
effort
mitig
limit
klapperich
group
develop
invent
method
nucleic
acid
extract
amplif
detect
fulli
integr
singl
paper
fluidic
devic
accomplish
dna
clinic
sampl
precipit
solut
appli
paper
membran
wash
ethanol
remov
impur
lamp
reaction
reagent
includ
fitcconjug
forward
biotinyl
revers
loop
primer
appli
sampl
port
seal
min
heat
step
hot
plate
amplifi
solut
wick
onto
later
flow
assay
equip
antifitc
antibodi
test
line
streptavidinco
aunp
detect
figur
presenc
target
primer
hybrid
amplifi
genet
materi
form
sandwich
later
flow
assay
result
visibl
test
line
signal
allinon
paperbas
nucleic
acid
test
perfect
exampl
target
extract
amplif
innov
combin
metalbas
detect
element
integr
allow
complex
nucleic
acid
detect
protocol
perform
point
care
previous
possibl
wellequip
laboratori
move
forward
sever
consider
must
address
includ
integr
laboratoryfre
heat
element
reduc
number
user
step
largescal
manufactur
feasibl
nonetheless
combin
paperbas
devic
develop
klapperich
group
simpl
integr
heat
element
similar
nina
devic
could
allow
sensit
informationrich
nucleic
acid
detect
low
resourc
set
would
enabl
case
manag
elimin
strategi
precis
carri
nearli
healthcar
set
applic
inorgan
chemistri
nanomateri
pointofcar
infecti
diseas
diagnosi
enhanc
sensit
specif
diagnost
test
lead
improv
outcom
reduc
transmiss
sampl
prepar
detect
method
present
herein
promis
exampl
metalbas
strategi
expand
usecas
scenario
diagnost
test
result
access
care
would
otherwis
unattain
howev
also
seen
metalbas
strategi
improv
review
diagnost
sensit
specif
lead
complex
test
potenti
requir
user
step
expertis
time
complet
tradeoff
complex
cost
speed
must
weigh
potenti
impact
improv
sensit
specif
could
given
usecas
scenario
exampl
case
morbid
control
goal
reduc
preval
highintens
infect
demand
simpl
afford
rapid
test
like
outweigh
need
highli
sensit
test
elimin
phase
howev
goal
complet
interrupt
local
transmiss
high
sensit
test
imper
detect
treat
lowdens
infect
consequ
need
sensit
diagnost
like
outweigh
small
increas
test
complex
cost
elimin
campaign
evalu
variou
inorgan
complex
nanomateri
advantag
caveat
becam
appar
differ
class
materi
properti
materi
directli
affect
appli
diagnost
nobl
metal
nanoparticl
frequent
incorpor
paperbas
assay
later
flow
assay
visual
signal
readout
stabil
superior
molar
absorpt
despit
strong
optic
signal
nobl
metal
nanoparticl
afford
colorimetr
assay
often
still
limit
poor
sensit
potenti
limit
impact
usecas
scenario
elimin
campaign
better
sensit
need
essenti
three
metalbas
strategi
discuss
review
improv
sampl
prepar
biomark
enrich
luminesc
detect
probe
signal
amplif
techniqu
imacfunction
materi
use
sampl
prepar
collect
repres
one
approach
improv
assay
sensit
enrich
biomark
concentr
sampl
prepar
method
demonstr
increas
diagnost
sensit
method
add
number
user
step
metalbas
sampl
prepar
perhap
simplest
three
metalbas
approach
increas
sensit
howev
truli
impact
need
incorpor
diagnost
develop
end
user
mind
overal
workflow
consid
assay
step
minim
altern
nobl
metal
nanoparticl
replac
luminesc
detect
probe
afford
greater
sensit
quantum
dot
lanthanid
chelatedop
nanoparticl
upconvert
phosphor
nanoparticl
potenti
offer
improv
sensit
colorimetr
label
albeit
differ
mechan
luminesc
inorgan
complex
incorpor
proofofprincipl
assay
detect
infecti
diseas
biomark
yet
util
fielddeploy
format
lack
sensit
aforement
nanomateri
quantum
dot
upconvert
phosphor
nanoparticl
also
capabl
multiplex
could
benefici
case
manag
although
variou
luminesc
nanoparticl
offer
improv
sensit
also
requir
instrument
signal
readout
increas
cost
complex
signal
readout
luminesc
nanoparticl
must
therefor
consid
develop
diagnost
strategi
combat
infecti
diseas
lastli
metalbas
signal
amplif
techniqu
could
incorpor
improv
sensit
almost
signal
amplif
techniqu
discuss
review
metalloenzymebas
amplif
nanoparticl
dissolut
nanoparticl
enzym
mimic
reduct
nanoparticl
enlarg
biobarcod
offer
colorimetr
readout
improv
sensit
howev
improv
come
cost
increas
number
assay
step
thu
longer
total
assay
time
effort
lfa
develop
loynachan
et
al
demonstr
progress
toward
fieldfriendli
signal
amplif
method
improv
eas
use
time
result
must
made
translat
method
primari
healthcar
facil
metalbas
strategi
improv
sensit
clear
simplifi
user
interfac
signific
challeng
remain
asid
user
interfac
sever
challeng
translat
novel
diagnost
strategi
must
consid
implement
includ
need
clinic
valid
potenti
largescal
manufactur
avail
distribut
channel
figur
workflow
detect
nucleic
acid
paper
fluidic
devic
differ
dye
use
illustr
variou
compon
assay
dnacontain
sampl
blue
dye
ad
sampl
port
wick
test
capillari
action
b
test
wash
twice
ethanol
yellow
also
flow
test
g
absorb
pad
remov
discard
h
lamp
reaction
mix
ad
sampl
port
test
fold
protect
samplelamp
mixtur
evapor
test
heat
hot
plate
min
hydrophob
barrier
remov
sampl
port
expos
top
bottom
allow
come
contact
lfd
strip
dna
elut
j
sampl
elut
wick
length
test
strip
gener
signal
adapt
permiss
ref
copyright
royal
societi
chemistri
review
integr
current
health
system
metalbas
strategi
improv
infecti
diseas
diagnost
present
review
demonstr
level
feasibl
small
set
patient
mock
clinic
sampl
howev
new
technolog
must
clinic
valid
larg
set
patient
sampl
endem
region
implement
studi
provid
insight
diagnost
perform
toler
daytoday
interpati
variat
appropri
clinic
context
rigor
draw
attent
challeng
weak
would
otherwis
go
unnot
research
laboratori
set
product
scalabl
novel
diagnost
technolog
anoth
import
consider
success
translat
even
research
phase
diagnost
develop
materi
choic
devic
design
fabric
base
part
manufactur
scalabl
order
streamlin
implement
mani
metalbas
strategi
present
review
particularli
divers
inorgan
nanoparticl
detect
probe
use
later
flow
assay
advantag
context
easili
integr
exist
lfa
manufactur
infrastructur
beyond
laboratori
import
consid
distribut
channel
novel
tool
integr
exist
health
system
regionspecif
health
deliveri
system
respect
regulatori
approv
ultim
defin
novel
diagnost
devic
implement
exampl
one
region
rapid
test
infecti
diseas
may
perform
local
health
clinic
run
nation
ministri
health
wherea
anoth
area
privat
run
dispensari
may
common
sourc
primari
health
care
understand
structur
differ
health
deliveri
system
well
respect
avail
resourc
could
impact
devic
design
research
phase
although
mani
consider
barrier
translat
novel
technolog
clinic
set
optimist
continu
develop
metalbas
pointofcar
diagnost
strategi
profound
impact
global
health
return
exampl
present
introduct
ultrasensit
detect
method
present
review
adapt
use
primari
healthcar
facil
time
result
infant
hiv
diagnosi
point
need
would
significantli
reduc
area
like
burkina
faso
would
enabl
earlier
initi
effect
antiretrovir
therapi
drastic
reduc
infant
mortal
stem
opportunist
infect
final
continu
increas
connect
lowand
middleincom
countri
coupl
sensit
diagnost
allow
realtim
diseas
surveil
intervent
analysi
epidemiolog
studi
connect
diagnost
potenti
acceler
commun
field
worker
local
health
outpost
district
hospit
nation
health
ministri
abil
rapidli
convey
diagnost
result
could
enabl
activ
case
detect
strategi
also
would
provid
faster
respons
epidem
ebola
zika
outbreak
faster
respons
could
potenti
reduc
mortal
improv
clinic
outcom
metalbas
strategi
sampl
prepar
signal
gener
show
great
promis
use
develop
improv
sensit
diagnost
devic
lowresourc
set
devic
coupl
connect
fielddeploy
instrument
empow
rapid
respons
effect
control
success
elimin
infecti
diseas
worldwid
usher
era
sustain
improv
global
health
american
associ
advanc
scienc
fellow
past
decad
unravel
mechan
heme
detoxif
within
parasit
plasmodium
falciparum
caus
agent
malaria
addit
made
import
contribut
understand
hemozoin
immunomodulatori
activ
parasitehost
interact
mechan
action
antimalari
compound
develop
biomark
lowresourc
diagnost
recent
effort
focus
challeng
innov
lowresourc
diagnost
focus
primarili
malaria
biomark
new
approach
format
improv
perform
diagnost
detect
asymptomat
patient
drugresist
infect
drugsensit
patient
lab
work
field
macha
zambia
cape
town
south
africa
san
marco
peru
work
support
nation
institut
health
nihfogarti
intern
center
bill
melinda
gate
foundat
vanderbilt
univers
laboratori
innov
global
health
technolog
cfm
kar
acknowledg
support
nation
scienc
foundat
graduat
research
fellowship
program
grate
acknowledg
shelli
richard
tireless
proofread
effort
sharpen
manuscript
